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ABSTRACT 
 
ALEJANDRO RAÚL MOLINELLI 
 
ORGANIC AND INORGANIC ARSENIC COMPOUNDS SENSITIZE HUMAN BRONCHIAL EPITHELIAL 
CELLS TO HYDROGEN PEROXIDE-INDUCED DNA DAMAGE 
 
(Under the direction of Michael C. Madden, Ph.D.) 
 
 
 Arsenic is an environmental contaminant that can induce lung cancer via ingestion or 
inhalation.  Arsenic undergoes a series of metabolic changes in the body were the inorganic 
species of the semi-metal (commonly found in the environment) undergo a series of redox 
and methylation reactions.  Recent evidence suggests that organic trivalent arsenicals might 
be more cytotoxic and genotoxic than inorganic arsenicals.   Several hypotheses have been 
proposed to explain its carcinogenic mode of action but no definitive conclusion has been 
documented.  However, multiple studies suggest that arsenic might potentiate the effects of 
other agents.  The purpose of this project was to evaluate the cytotoxicity and DNA damage 
potential of organic (dimethylarsine iodide, DMAs3+) and inorganic (sodium arsenite, iAs3+) 
arsenic compounds to human bronchial epithelial cells and whether the arsenicals had any 
effect on hydrogen peroxide-induced DNA damage.  Hydrogen peroxide is present in the 
airways due to cellular metabolism, and is increased in response to inflammation.  We found 
that DMAs3+ was more cytotoxic and induced more DNA damage (as assessed via the 
alkaline single cell gel electrophoresis assay) than iAs3+ after exposure for 4 h in the BEAS-
2B (transformed human bronchial epithelium) cell line.  However, both arsenic compounds 
 iv 
sensitized the BEAS-2B cells to H2O2-induced DNA damage.  Upon further examination of 
the factors that could account for the sensitization we found that the BEAS-2B cells 
accumulate more As after exposure to DMAs3+ than after exposure to iAs3+.  This finding 
could partly explain the sensitization observed, thus, we assessed whether blocking As efflux 
transporters would affect the sensitization to H2O2.  However, no significant changes were 
observed between the cells that had received the efflux transporter inhibitors and the controls.  
We also assessed whether reduced glutathione (GSH) was involved in the results observed.  
After increasing or decreasing cellular GSH we observed that DMAs3+-induced sensitization 
of the cells to H2O2-induced DNA damage is dependent on the levels of GSH.  An increase in 
GSH levels attenuates the sensitization, and a decrease in GSH increases the sensitization.  It 
is possible that GSH serves a protective role in airway epithelial cells by scavenging 
methylated arsenic compounds.           
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“An expert is a man who has made all the  
mistakes which can be made  
in a very narrow field.” 
 
Niels Bohr 
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CHAPTER 1 
INTRODUCTION 
 
Literature Review: 
 
    Arsenic sources in the environment.  Arsenic is a semi-metal that occurs in trace 
quantities in all of the earth’s matrices (rocks, soil, water, and air).  There are more than 200 
minerals that contain arsenic, the most common one being arsenopyrite (FeAsS) (IPCS, 2001, 
section 3.1).  About 1/3 of the atmospheric flux of arsenic is of natural origin, stemming from 
volcanic activity.  The rest is emitted to the environment from mining, non-ferrous metal 
smelting, and fossil fuel combustion.  In urban areas mean air arsenic concentrations can vary 
between 3 – 200 ng/m3.  However in some places the concentrations can exceed 1000 ng/m3 
((near a Cu smelter in Chile) (IPCS, 2001, section 5.1.1)).  Arsenic in the air is primarily 
bound to particulate matter (especially that with an aerodynamic diameter < 2.5 µm).  
Because airborne particulate matter usually contains a heterogeneous mixture of metals there 
is always the potential for interaction among them.  (IPCS, 2001, section 4.1).  Arsenic is a 
common contaminant of groundwater.  Some of the areas most affected include the West 
Bengal delta in India, Inner Mongolia in China, Chile, Argentina, Mexico, and the western 
United States (Fig. 1-1).  Inorganic arsenic can be found in groundwater at concentrations 
ranging from 1 µg/L to as high as 3 mg/L (IPCS, 2001, section 5.1.4).  In Orange County, 
NC a concentration of 86 µg/L was reported from a well (Chapel Hill News, 2003).  In the 
 2 
USA the current limit (set by the US EPA) for arsenic in drinking water is 10 µg/L.  
However, the agency is debating whether to allow small municipalities to be exempt from the 
standard due to the cost of removal.  The previous standard established the limit of arsenic in 
drinking water at 50 µg/L.  Arsenic can also occur in open ocean seawater at concentrations 
ranging from 1 – 2 µg/L.  Arsenic kinetics are similar to phosphorous, thus in low phosphate 
environments marine organisms tend to accumulate it. The most common form of arsenic 
present in marine organisms is organic (e.g. arsenosugars, arsenobetaine).  Arsenic also has 
some commercial uses including as a wood preservative (70%, mainly chromated copper 
arsenate), in agricultural chemicals (22%), and in glass, pharmaceuticals, and non-ferrous 
alloys (8%) (IPCS, 2001, section 3.0).   
 
    Arsenic and human health.  Arsenic has been recognized and used as a poison for 
hundreds of years and is one of the oldest and most studied xenobiotics known to toxicology.  
Ingestion of large doses leads to an acute gastrointestinal syndrome characterized by garlic-
like taste, burning lips, and difficulty swallowing.  This can be followed by vomiting and 
vomiting of blood.  This syndrome is caused by paralysis of capillary control in the GI tract.  
After the initial GI problems, multi-organ failure can occur, followed by death (IPCS, 2001, 
section 8.0).  Lethal doses have been estimated from 2-21 g.  In one report continuous 
ingestion of 108 mg As/L for one week killed 2 of 9 persons exposed, caused encephalopathy 
in 4, and GI symptoms in 8 (Armstrong et al., 1984).  Chronic, non-lethal exposure to arsenic 
can cause peripheral vascular disease (Black-foot disease), cardio and cerebrovascular 
disease, hypertension, peripheral neuropathy, cirrhosis and non-cirrhotic hypertension, and 
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diabetes mellitus (IPCS, 2001, section 8.0).  Chronic exposure to arsenic can also lead to 
cancers of the skin, liver, kidneys, bladder, and lungs (IPCS, 2001, section 8.0).    
 
    Arsenic induced carcinogenesis.  Cancer is a collection of diseases characterized by 
uncontrolled cell proliferation leading to the formation of tumors, which may spread 
throughout the body.  Cancer arises from the accumulation of mutations in genes of somatic 
cells that generally regulate cell multiplication.  These mutations can be caused by a myriad 
of environmental, genetic, or endogenous factors.  Chemical carcinogenesis refers to the 
process by which exogenous chemicals cause cancer.  This process can be defined as having 
three different steps.  The first step is initiation, where a mutation confers growth advantage 
to the cell.  The second step, promotion, involves the clonal expansion of the initiated cell 
population by increased cell proliferation, or inhibition of apoptosis.  The last step, 
progression, is characterized by the development of malignant tumors from benign lesions 
(Klaunig, 1998).   
    The adverse health effects of arsenic have been well described but there are still many 
questions unanswered regarding its carcinogenic mode of action (MOA).  Some of the 
hypotheses to explain its carcinogenic MOA have centered on its induction of mutations and 
chromosomal aberrations, its effects on signal transduction, cell cycle control, differentiation 
and apoptosis, its induction of oxidative stress, and its alterations of gene expression (NRC, 
2001).  For both the inhalation and oral routes of exposure the lung is one of arsenics’ target 
organs for carcinogenesis (IPCS, 2001, section 8.0).   
    Ambient particulate matter exposure has been linked with an increase in lung cancer 
mortality (Dockery et al., 1993, Pope et al., 2002).  Even though it might be hypothesized 
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that arsenic levels in outdoor ambient air alone are probably too low to be of concern for 
human health effects, it is important to consider other factors.  The first one is the finding 
that arsenic, even though not genotoxic by itself, can potentiate the carcinogenic potential of 
other substances.  Furthermore, it has been found that concentrations of arsenic (in various 
forms) lower than 1 µM can exert biological effects on in vitro systems.  Some of these 
findings include the induction of oxidative DNA damage, altered DNA methylation and gene 
expression, changes in the intracellular levels of the mdm2 and p53 proteins, the inhibition of 
thioredoxin reductase, the inhibition of pyruvate dehydrogenase, altered colony-forming 
efficiency, formation of DNA-protein crosslinks, induction of apoptosis, altered regulation of 
DNA repair genes, stimulation and inhibition of normal human keratinocyte cell 
proliferation, and altered function of the glucocorticoid receptor (NRC, 2001).  Zhang et al. 
(2003) found that sub-micromolar doses of arsenic increase telomerase activity in HL-60 and 
HatCat cells.  Finally, it is important to mention that numerous investigations have indicated 
that metals (including arsenic) may play an important role in the toxicity of airborne 
particulate matter (US EPA, 2004). 
 
    Arsenic metabolism.  Inorganic arsenic generally undergoes two different metabolic 
changes in humans (Fig. 1-2).  Pentavalent forms of the semi-metal (arsenate, iAs+5; 
methylarsonic acid, MAs+5; dimethylarsinic acid, DMAs+5) can be reduced to their trivalent 
forms (arsenite, iAs+3; methylarsonous acid, MAs+3, dimethylarsinous acid, DMAs+3) by 
oxidizing glutathione.  Additionally, iAs+3 and DMAs+3 can be methylated by As+3-
methyltransferases that use S-adenosylmethionine as the -CH3 donor group (Thomas et al., 
2001 and Styblo et al., 2002).  Recently Thomas et al. (2004) designated rat liver arsenic 
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methyltransferase as cyt19, and suggested that this protein has orthologous genes in mice and 
humans.  The authors postulate that cyt19 can catalyze all the metabolic reactions that 
inorganic arsenic undergoes.  Waters et al. (2004) demonstrated that the addition of arsenite 
to rat recombinant As3+ methyltransferase yields monomethylated and dimethylated 
arsenicals and trimethylarsine oxide (TMAO).  However, the addition of glutathione 
suppressed TMAO formation.  Hayakawa et al. (2005) suggest that As-GSH complexes such 
as arsenic triglutathione and monomethylarsonic diglutathione are substrates for cyt19.  The 
authors postulate a novel metabolic pathway where the formation of methylated arsenic 
metabolites is not via oxidative methylation of iAs3+ and MAs3+ but via the As-GSH 
intermediates.  Taken together these studies underscore the importance of intracellular 
glutathione in the oxidative methylation of arsenic.   
    Although arsenic methylation has been traditionally viewed as a detoxification pathway, 
several studies provide evidence that methylated arsenic metabolites can be more cytotoxic 
(Styblo et al., 2002) and genotoxic (Mass et al., 2001) than iAs, particularly DMAs+3.  In 
humans arsenic accumulates primarily in hair and urine, followed by the skin and lungs 
(IPCS, 2001, section 6.1.2).  Human bronchial epithelial cells incubated with 0.05 µM iAs+3 
for 24 h methylate ~1% of the available arsenic (to MAs).  Human bronchial epithelial cells 
(cultured under air-liquid interface conditions that induce morphology similar to in vivo 
cells) when exposed to 0.05 µM iAs+3 for 48 h produce MAs and DMAs representing 2.8% 
and 0.5% of the total arsenic (Styblo et al., 2000).  These results suggest that arsenic 
metabolism in lung cells is minimal, though this may be due to a small number of individual 
donors or due to cell culture conditions.  The methylating capacity of human lung epithelium 
in vivo is not known.  Loffredo et al. (2003) point out that variation in arsenic metabolism 
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may affect the risk of carcinogenesis to individuals.  By analyzing urinary arsenic 
metabolites from different populations the authors conclude that there are sex and ethnic 
variations in arsenic metabolism.  The authors stress that their results are consistent with 
functional genetic polymorphisms in arsenic methylation. 
 
    Arsenic transport in cells.  Metals are transported into and out of cells by several, often 
shared mechanisms.  Some general mechanisms include transport inside vesicles (e.g. Fe-
ferritin), use of metal selective transporters (e.g. DMT1), and the use of transporters for other 
substances (e.g. phosphate or sulfate transporters, voltage-gated channels).  Vesicle insertion 
and retrieval can occur as a receptor mediated process, via the fluid-phase, or as adsorptive 
endocytosis (Ballatori, 2002).  It was thought that iAs+3 could enter cells by passing through 
the cell membrane as it is uncharged at physiological pH.  However, it is now proposed that 
iAs+3 enters the cell using aquaglyceroporins 7 and 9, which normally transport water and 
glycerol (Liu et al., 2002).  Additionally, aquaglyceroporin 9 might also transport 
methylarsonous acid (Liu et al., 2006).  It is thought that iAs+5 (and also vanadate) can enter 
cells by using phosphate transporters (Rossman, 2003).  Organometallic compounds 
(including methylated As) are thought to enter cells using organic solute transporters (e.g. 
organic anion transporters) (Ballatori, 2002).  Arsenic is thought to be transported out of the 
cell via the multidrug resistance-related protein 1 (Mrp1), a member of the ATP-binding 
cassette (ABC) superfamily of proteins (Leslie et al., 2001).  It can also be transported out of 
the cell by p-glycoprotein, another ABC superfamily member (Lehmann et al., 2001).  
Known inhibitors of Mrp1 include indomethacin and MK-571, and for p-glycoprotein, 
verapamil.  It has been postulated that As-glutathione complexes are required for the biliary 
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excretion of arsenic by the MRP2/cMOAT transporter (Kala et al., 2000).  Human bronchial 
epithelial cells in culture are known to express both Mrp1 and p-glycoprotein (Lehmann et 
al., 2001).    
 
    Arsenic interactions with other agents.  It appears that arsenic is capable of potentiating 
the effects of other agents, including carcinogens.  One example would be benzo[a]pyrene, 
an airborne pollutant whose ubiquitous presence in the atmosphere makes it a relevant human 
risk (Maier et al., 2002).  Moreover, additive to synergistic interactions in lung cancer risk 
have been shown to ocurr among smokers who have been occupationally exposed to arsenic 
(Pershagen et al, 1981; Jarup & Pershagen, 1991; Hertz-Picciotto et al., 1992).  It has also 
been shown that arsenic can act as a skin co-carcinogen with UV light in a mouse model 
(Burns et al., 2004).  Hartwig and collaborators (2003) suggest that PARP inhibition after 
incubation of HeLa cells with concentrations as low as 10 nM iAs+3 for 18h lead to increased 
sensitivity to H2O2-induced oxidative damage.  It has also been proposed that arsenic can act 
in conjunction with other metals (e.g. Cd) to cause DNA repair inhibition and DNA damage 
(Hartwig & Schwerdtle, 2002).  Finally, Sturlan et al. (2003) found that arsenic trioxide can 
react with docosahexaenoic acid producing reactive oxygen species and lipid peroxidation. 
 
    Arsenic and oxidative stress.  Reactive oxygen species (e.g. H2O2, -OH, O2-•), can 
directly or indirectly (by altering signal transduction pathways) damage DNA and proteins.  
Numerous studies point out that metals (including arsenic) may play an important role in the 
toxicity of airborne particulate matter, possibly via generation of reactive oxygen species 
(ROS).  ROS can react with membrane lipids and other macromolecules to produce carbonyl 
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compounds, among other substances, that subsequently can mediate biological responses 
such as the induction of prostaglandin production (Leikauf et al., 1995) or inhibition of DNA 
repair (Grafstrom et al., 1985).  Oxidative stress has been proposed as one of the possible 
modes of action during arsenic induced carcinogenesis.  Trivalent arsenicals are capable of 
electronic interactions with biological molecules via their unshared 4s electron pair (Kitchin 
& Ahmad, 2003).  Yamanaka and collaborators (1991, 1997, 2001) proposed that cycling 
between DMAs+5 and dimethylarsine (a gaseous form of arsenic found in exhaled breath of 
DMAs+5 treated mice) could generate the superoxide anion.  They propose that DMAs+5 can 
generate dimethylarsine by using NAD(P)H; subsequently, dimethylarsine can react with O2 
to generate the superoxide anion and DMAs+5.  Del Razo and collaborators (2001) suggest 
that the oxidation of iAs+3 to iAs+5 can occur in a non-enzymatic manner under physiological 
conditions.  This reaction would generate H2O2.  The authors also suggest that ROS can be 
formed when similar reactions occur to methylated arsenic metabolites formed by enzymatic 
reactions.  Using a cell-free system and electron spin resonance spectroscopy Nesnow and 
collaborators (2002) demonstrated that trivalent methylated arsenicals induce DNA damage 
via ROS generation.  This suggests that methylated arsenic species could induce ROS 
without cellular uptake.  Arsenic can also interact with protein sulfhydryl groups, leading to 
impaired protein function and cellular injury.  This mechanism is especially relevant when 
antioxidant proteins, such as glutathione, are damaged (Del Razo et al., 2001).  Another 
pathway by which arsenic could generate ROS is via the metabolism of dimethylated 
arsenicals to dimethylarsenic radical and dimethylarsenic peroxy radical from the reaction of 
molecular oxygen and dimethylarsine (gas).  However, these reactions to date have only been 
shown to ocurr in mice (Yamanaka et al., 2004).  Further evidence suggesting that arsenic 
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causes oxidative stress is provided via its induction of heme oxygenase (HO) in non-
pulmonary mammalian cells.  Under normal metabolic conditions HO catalyzes the ring 
opening of heme producing biliverdin, carbon monoxide, and iron.  It uses molecular oxygen 
and electrons donated by NADPH-cytochrome P-450 reductase.  Heme oxygenase activity 
causes the redox potential to shift towards reduction, thus it has been proposed as a marker of 
oxidative stress (Rossman, 2003).  Hei & Filipic (2004) proposed a model on the pathways of 
ROS and reactive nitrogen species (RNS) mediation of genotoxicity on mammalian cells 
exposed to arsenic.  The authors propose that iAs+3 induces the formation of ROS and RNS 
immediately after entering the cell.  These ROS and RNS increase intracellular oxidative 
stress and generate DNA adducts and mutations.  Furthermore, mitochondrial damage and 
lipid peroxidation contribute to the genotoxicity.  The authors mention that arsenic can 
stimulate membrane bound NADPH oxidase, enhancing ROS production.  Damage to the 
mitochondrial membrane may result in leakage of superoxide anions and production of 
peroxynitrite.   
 
    Airway inflammation and oxidative stress.  The onset of inflammation is intimately tied 
with an increase in oxidative stress as inflammatory cells secrete reactive oxygen species to 
combat infection.  Studies in our laboratory and elsewhere have demonstrated that in vivo 
exposure of humans and rodent models to metals present in airborne particulate matter can 
induce an inflammatory response in the airways characterized by neutrophil and macrophage 
infiltration, cytokine production, total protein increases (indicative of leakage in airway 
epithelial cell permeability), and thickening of the airway epithelium (Ghio, 2004; Donaldson 
and Tran, 2002).  The presence of chronic inflammation has been tied to lung carcinogenesis 
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(Ballaz & Mulshine, 2003) and chronic airway disease (MacNee, 2001).  In vitro exposures 
to metal rich ambient airborne particulate matter using cultured airway epithelial cells 
generally have shown increased production of inflammatory mediators.  For example, Samet 
et al. (1996) observed increases of the arachidonic acid metabolites prostaglandin E2 and 15-
eicosatetraenoic acid after exposure of cultured bronchial epithelial cells (and the BEAS-2B 
cell line) to residual oil fly ash (ROFA), a transition metal-rich particulate matter shown to 
induce oxidative stress in vitro an in vivo (Ghio et al., 2002).  The authors demonstrated that 
the increase was probably due to the up-regulation of cyclooxygenase-2 (COX-2), and that it 
also occurred after intratracheal instillation of ROFA in animals.  The expression of the pro-
inflammatory cytokine IL-8 (a potent neutrophil chemoattractant) can be modulated by the 
JNK, p38, and NF-κB pathways which are known to be affected by airborne particulate 
matter (Samet et al., 1998).  Vanadium and ROFA have also been shown to elevate the 
expression of IL-8, IL-6, and tumor necrosis factor-α (TNF-α) in bronchial epithelial cells 
(Carter et al., 1997; Veronesi et al., 1999).  Finally, the presence of activated inflammatory 
cells in the airways serves as an indirect mechanism of ROS production as neutrophils, 
macrophages, and eosinophils release hydrogen peroxide, reactive nitrogen species (RNS), 
and other cytotoxic agents once activated.   
 
    Arsenic and inflammation.  In vitro studies with normal human epidermal keratinocytes 
have shown that low concentrations of trivalent arsenicals can induce the inflammatory 
proteins GM-CSF, TNF-α, and IL-6 (Vega et al., 2001).  Jaspers and collaborators (1999) 
found that exposure to high concentrations of arsenite induce IL-8 (a neutrophil chemotaxin) 
in human bronchial epithelial cells.  Furthermore, experiments performed by Andrew et al. 
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(2003) suggest that low doses of arsenic (5 µM) induce a survival response on BEAS-2B 
cells characterized by an up-regulation of hypoxia-inducible factor 1α, heme-oxygenase, and 
inflammatory cytokines.  In vivo studies with rats point out that intratracheal instillation with 
arsenic metal particulates generate an inflammatory response and pneumonocyte hyperplasia 
(Webb et al., 1986).  It has also been found that intratracheal instillation of rats with arsenic 
trioxide leads to cystatin-c and fibronectin production (Huaux et al., 1995).  A report on 
Taiwan residents exposed to arsenic in drinking water shows increased expression of several 
inflammatory cytokines and growth factors in blood (Wu et al., 2003).  Because airway 
inflammation can be considered an indirect mechanism of ROS production with the potential 
to induce DNA damage, the effects of arsenic on inflammatory responses have to be 
considered when evaluating its genotoxicity.         
 
    Iron and oxidative stress.  Iron is an essential metal for life, being involved in numerous 
cellular functions such as the transport of oxygen in hemoglobin.  However, iron can also 
participate in reactions that generate ROS such as: 
 
Fe+2 + O2 → Fe+3 + O2-•, 
Fe+2 + O2-• + 2H+ → Fe+3 + H2O2,  
Fe+2 + H2O2 → Fe+3 + •OH + -OH (Fenton reaction). 
 
    The generation of superoxide (O2-•), H2O2, and hydroxyl radical (•OH), as well as 
production of ferryl (FeO+2) and perferryl (Fe+3O2-) radicals can cause oxidative stress (Turi 
et al., 2004).  Several reports suggest that some iron-related diseases, as well as increased 
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body iron stores increase cancer risk (Toyokuni, 1996).  Iron-induced oxidative stress can 
result in redox regulation failure leading to lipid peroxidation and oxidative DNA and protein 
damage.  It can also result in alteration of signal transduction pathways related to oxidative 
stress protection.  Both these processes can play a role in iron-induced carcinogenesis 
(Toyokuni, 1996).  It has also been reported that arsenic can cause transformation in human 
osteosarcoma cells by altering iron homeostasis, mainly through its interactions with ferritin 
and the transferrin receptor (Wu et al., 2006).   
 
    Iron binding and transport proteins and oxidative stress.  Iron, which is essential for 
life, has multiple transport processes.  In airway cells it is thought that iron enters cells via 
transferrin or lactoferrin receptors.  Non-transferrin bound iron can be transported inside the 
cell by complexation (of low-molecular-weight iron) to endogenous ligands.  The natural 
resistance-associated macrophage protein 2 (Nramp2) or divalent metal transporter 1 
(DMT1) can transport ferrous iron across the cell membrane (Turi et al., 2004).  Iron can be 
transported out of airway cells via ferritin or transferrin by unknown mechanisms.  
Alternatively, ferrous iron can be transported out of the cell via the metal transport protein 1 
(MTP1) (Turi et al., 2004).             
    As mentioned above, ferritin plays an important role in iron transport and storage.  If iron 
is released from ferritin it can potentially participate in the Fenton reaction and generate 
oxidative stress.  Kitchin & Ahmad (2003) provide evidence that various arsenic compounds 
can release iron from ferritin.  This situation provides another mechanism for arsenic to 
induce oxidative stress and underscores the importance of examining potential interactions of 
arsenic with proteins involved in iron metabolism.   
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    In our laboratory Ghio et al. (2005) have suggested that metal transporters can be regulated 
to modulate oxidative stress.  When airway epithelial cells (BEAS-2B) are exposed to 
vanadium, -IRE DMT1 mRNA and protein levels, plus iron transport capacity diminishes.  
On the contrary, when airway cells are exposed to iron, -IRE DMT1 mRNA and protein 
levels, plus iron transport capacity increases.  The authors suggest that extracellular (airway 
side) prooxidants such as iron are sequestered by airway cells in order to diminish oxidative 
stress.  When airway epithelial cells pre-treated with vanadium are exposed to residual oil fly 
ash (a metal rich combustion by-product) cell lipid peroxide levels (indicators of oxidative 
stress) increase when compared to cells pre-treated with vehicle alone.  On the contrary, 
when the cells are pre-treated with iron then exposed to oil fly ash, cell lipid peroxide levels 
are lower than those in vehicle pre-treated cells.  The authors demonstrate that this effect is 
tied to increased or decreased uptake of iron (present in the fly ash) after pre-exposure.  
Finally, 80% of the population expresses -IRE DMT1 in lung tissues.  Moreover, genetic 
polymorphisms in metal transport genes suggest that some populations might be more 
susceptible to xenobiotics.  
 
Purpose: 
 
    The main objective of this project is to examine in what manner arsenic and hydrogen 
peroxide (an oxidant released by inflammatory cells) together damage lung cell DNA.  This 
interaction may provide important information on the carcinogenic mode of action of arsenic.  
To do this work we exposed BEAS-2B cells (a transformed cell line of human bronchial 
epithelia) to both inorganic (sodium arsenite, iAs3+) and organic (dimethylarsine iodide, 
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DMAs3+) arsenicals.  We subsequently exposed the cells to H2O2 and monitored DNA 
damage via alkaline single cell gel electrophoresis (SCGE).  The BEAS-2B cell line has 
similar responses and sensitivity to cultured human airway epithelial cells.     
    We will also examine the potential role that the modulation of the metal transport protein 
DMT1 (primarily an iron transporter) has on H2O2-induced DNA damage in human bronchial 
epithelial cells pre-treated with arsenic compounds, iron or vanadium.  Finally, we will 
investigate what role might the arsenic transporters Mrp1 and P-glycoprotein play on the 
modulation of DNA damage induced by H2O2.    
    The global hypothesis in this project is that arsenic compounds will act as co-carcinogens 
with H2O2 by sensitizing the cells to DNA damage induced by hydrogen peroxide.   
 
Justification: 
 
    As already mentioned, arsenic is a ubiquitous pollutant of air and water present throughout 
numerous locations in the world.  Epidemiological studies provide evidence that arsenic 
exposure is mainly associated with cancers of the skin, bladder and lung.  Several hypotheses 
have been proposed to explain how arsenic can cause cancer.  Recent studies point out that 
arsenic can act as a co-carcinogen with multiple agents such as UV light or benzo[a]pyrene.  
Following that line of research our study will explore whether arsenic can modify oxidative 
stress and DNA damage induced by H2O2.  Hydrogen peroxide is an endogenous oxidant 
released by inflammatory cells and is usually present in the lungs, especially when other 
adverse conditions (such as disease) are occurring (Gerritsen et al., 2005).     
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    In these studies we focus on whether arsenic lung carcinogenicity can be partly explained 
by its induction of DNA damage when given together with H2O2.  It is widely accepted that 
sustained DNA damage can lead to initiation of cells in the current scheme of cancer 
development (Klaunig & Kamendulis, 2004).  We also investigate whether arsenic can cause 
DNA damage in human bronchial epithelial cells when the expression or activity of metal 
transport proteins is altered.  This objective is of particular importance as metals such as iron 
that are essential for normal biological functions can also act as oxidants.  There is evidence 
of genetic polymorphisms of metal transporters in humans.  If these polymorphisms have 
different activities, and if arsenic has any effect on them or vice-versa, some populations 
might exhibit differential susceptibility to arsenic.   
    In summary the most important goal of our research is to learn about the possible mode of 
action of arsenic induced lung carcinogenesis.  Knowledge of a carcinogen’s mode of action 
may help in the identification of susceptible populations and in the modification of public 
health management strategies. 
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Specific Objectives: 
 
The specific objectives of this dissertation are outlined below.  Each objective corresponds to 
a specific chapter in the text: 
 
1. Compare the cytotoxicity and DNA damage induced by exposure to organic and 
inorganic arsenicals in human bronchial epithelial cells (chapter 2).   
 
2. Determine whether exposure to arsenic compounds, iron, and vanadium can modulate 
DNA damage induced by hydrogen peroxide, a potent endogenous oxidant released 
by inflammatory cells (chapter 3).   
 
3. Determine the role of arsenic transport and antioxidant proteins on arsenic 
sensitizationof human bronchial ephitelial cells to H2O2-induced DNA damage 
(chapter 4). 
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Figure Legends: 
Figure 1-1.  Map of arsenic contamination of groundwater in the U.S.A.  Reprinted from 
U.S. Geological Survey, National Water Quality Assessment, National Analysis of Trace 
Elements, Arsenic in Ground Water of the US.  
URL:  http://water.usgs.gov/nawqa/trace/pubs/geo_v46n11/fig1.html.  (Accessed June, 
2006).  (Information is from a public domain source).        
 
Figure 1-2.  Metabolic pathway for arsenic.  MT = methyltransferase.   
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Figure 1-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19 
Figure 1-2 






	



	



	

	
	






	

	
	
CHAPTER 2 
 
Comparative cytotoxicity and DNA damage induced by organic and inorganic 
arsenicals in a human bronchial epithelial cell line 
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Disclaimer: The research described in this article has been reviewed by the National Health 
and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, and 
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approved for publication.  Approval does not signify that the contents necessarily reflect the 
views and policies of the Agency nor does mention of trade names or commercial products 
constitute endorsement or recommendation for use. 
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Abstract: 
    Arsenic is an environmental contaminant that can induce lung cancer via ingestion or 
inhalation.  Several hypotheses have been proposed to explain its carcinogenic mode of 
action but no definitive conclusion has been documented.  Arsenic undergoes a series of 
metabolic changes in the body were the inorganic species of the semi-metal (commonly 
found in the environment) undergo a series of redox and methylation reactions. The purpose 
of this paper is to examine the cytotoxicity and DNA damage induced by inorganic and 
organic arsenic compounds on human bronchial epithelial cells (BEAS-2B).  We found that 
with 4 or 24 h exposures the trivalent dimethylated arsenical, dimethylarsine iodide 
(DMAs3+), induced more cytotoxicity than the trivalent inorganic arsenical, sodium arsenite 
(iAs3+), using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
metabolism assay, neutral red uptake assay, and a clonal expansion assay.  The BEAS-2B 
cells accumulated 17.8% of the DMAs3+ dose given after a 4 h exposure but the cell 
associated arsenic decreased to 8.6% after a 24 h exposure; in contrast <1% of the iAs3+ was 
cell associated after 4 h and 24 h of exposure.  Exposure to DMAs3+ for 4 h induced an 
increase in DNA damage detectable by the alkaline single cell gel electrophoresis assay 
whereas the exposure to iAs3+ did not.  Taken together our results provide support to the 
hypothesis that exposure of lung epithelial cells to trivalent organic arsenicals induces more 
cytotoxicity and genotoxicity than exposure to inorganic arsenicals.  The role of arsenic 
metabolism in arsenic-induced lung carcinogenesis could play an important role in the 
development of this disease.    
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Introduction: 
    Arsenic contamination of drinking water is a global problem that is particularly serious in 
regions of Asia, South America, and the western United States.  Arsenic is also found in the 
air as a result of volcanic activity, fossil fuel combustion, mining, and other industrial 
activities (IPCS, 2001, section 4.1.1).  The ingestion of large (non-lethal) doses of arsenic 
disrupts the gastrointestinal, cardiovascular, and nervous systems.  Chronic exposure to low 
doses of arsenic (not causing acute symptoms) is associated with hyperkeratosis, changes in 
skin pigmentation, and cancers of the skin, bladder, and lungs (IPCS, 2001, section 8).  These 
changes have been reported after exposure to arsenic levels in water ≤ 50 µg/L (IPCS, 2001, 
section 8.7.2).  The toxicity of arsenic is dependent on its oxidation state (+3 or +5) and its 
chemical form (organic or inorganic).  However, it is generally agreed that trivalent 
arsenicals tend to be more toxic (IPCS, 2001, section 7.1.10).       
    Exposure to arsenic in air on occupational settings has also been linked to lung cancer.  
Enterline and collaborators (1987) have followed up a cohort of workers from a Tacoma, 
WA copper smelter for a period of more than 20 years.  The authors report standardized 
mortality ratios (SMR) for lung cancer of 188 in workers with less than 20 years of exposure 
and an SMR of 217 among workers with more than 20 years of exposure.  Studies on non-
ferrous smelters located in Montana and Sweden (Lubin et al. 2000; Järup & Pershagen, 
1991) also report an increased risk of lung cancer following long-term occupational 
exposures.  Järup (1992) also reports that the lung cancer risk is also present in its  “low 
exposure” category (<0.25 mg/m3 / year).  A study by DG Environment (2000) points out 
that ambient air levels of arsenic in urban areas ranges from 0.5-3 ng/m3 and is less than 50 
ng/m3 at industrial sites.  Arsenic in ambient air is primarily associated with particulate 
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matter (IPCS, 2001, section 5.2.1).  However, it is important to stress, as already mentioned, 
that arsenic exposure from drinking water can lead to lung cancer.   
    Some in vivo experiments involving repeated intratracheal instillation of As2O3 in rodents 
failed to give conclusive results related to lung cancer (Ishinishi et al., 1983, Pershagen et al., 
1984).  More recently Ng and collaborators (1998, 1999) reported that female C57BL/6J 
mice exposed to sodium arsenate (500 µg/L) in drinking water for a period of 26 weeks show 
an increased incidence in lung, liver, gastrointestinal, and skin cancer.  However, Rossman 
and collaborators (2001) report that after administering arsenite in drinking water (10 ppm) 
for 26 weeks to mice there was no increased incidence of tumors.  Multiple hypotheses have 
been proposed to explain the mechanisms behind arsenic-induced carcinogenesis.  These 
include the induction of chromosome abnormalities, altered growth factors, cell proliferation 
(mitogenic or compensatory regeneration), inhibition of DNA repair, altered expression of 
p53, gene amplification, altered DNA methylation, and oxidative stress (Kitchin, 2001).  
However, there is still no clear agreement on which of these possible mechanisms might play 
the leading role in cancer induction.        
    The purpose of this paper is to examine the cytotoxicity and DNA damage induced by 
inorganic and organic arsenic compounds on human lung cells using an airways epithelial 
cell line, BEAS-2B.  This cell line has been shown to have responses (e.g., DNA single 
strand breaks, cytokine and eicosanoid production) similar to normal human bronchial 
epithelial cells upon exposures to several pollutants, including ozone, hydrogen peroxide, and 
ambient particulate matter (Lee et al, 1996; Samet et al., 1996).  To assess cytotoxicity we 
used primarily three different classes of cell viability assays (Cook and Mitchell, 1989).  The 
clonal expansion assay measures reproductive capacity; the neutral red assay is a membrane 
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permeability assay that measures lysosomal fragility; and the MTT assay (reduction of 
tetrazolium salts) is a functional test that measures mitochondrial enzyme activity.  To 
measure DNA damage we utilized the single cell gel electrophoresis (SCGE) assay that 
measures DNA damage (mainly DNA single strand breaks) on individual cells.  We also 
used an aldehyde reactive probe to assess the presence of abasic sites in DNA.      
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Methods: 
Cell culture, chemicals, and in vitro exposures.  BEAS-2B cells (S6 subclone; passages 
72-95) were obtained courtesy of Drs. Curtis Harris and John Lechner from the National 
Institutes of Health (Reddel et al., 1988).  This is an immortalized line of normal human 
bronchial epithelium.  The cell media used was Clonetics (Rockland, ME) keratinocyte 
growth medium (KGM), which is essentially MCDB 153 medium supplemented with 5 
ng/ml human epidermal growth factor, 5 mg/ml insulin, 0.5 mg/ml hydrocortisone, 4 ml/L 
bovine pituitary extract, and 0.5 ml of GA-1000.  All cells were grown at 37°C and 5% CO2 
with fresh media being added every other day.  When cells reached 95% confluence they 
were split, counted, and seeded onto tissue culture plates.  Upon reaching 95% confluence 
the cells were then exposed to freshly prepared sodium arsenite (iAs3+) (Sigma, St. Louis, 
MO) or dimethylarsine iodide (DMAs3+) that was synthesized by Dr. William R. Cullen 
(University of British Columbia, Vancouver, Canada) using previously described methods 
(Cullen et al., 1984 and Styblo et al., 1997). Both arsenicals were dissolved in KGM for the 
exposures.  Throughout the cell exposure studies, a ratio of 0.6:1 media volume (ml) to well 
surface area (cm2) was maintained.  All chemicals used were purchased from Sigma Corp. 
(St. Louis, MO) unless otherwise noted.  In some SCGE assay experiments the cells were 
exposed to methyl-methanesulfonate (MMS) (Acros Organics, Geel, Belgium), a well known 
inducer of DNA breaks.    
 
Cell viability assays.  The neutral red bioassay (NRB) is based on the ability of viable cells 
to take-up and bind the neutral red dye (2,8-phenazinediamine, N8, N8, 3-trimethyl-
monohydrochloride) (Borenfreund and Puerner, 1985).  To assess cell viability the BEAS-2B 
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cells were seeded onto 96-well microtiter plates at a density of 5000 cells/well and allowed to 
grow overnight.  The following day the cells were washed with phosphate buffered saline 
(PBS) and exposed for 24 h to iAs3+ or DMAs3+.  After the 24 h period the arsenicals were 
removed, the cells were washed twice with PBS and incubated with the neutral red dye (100 
µg/ml in KGM) at 37°C and 5% CO2 for 3h.  The dye was then removed and the cells fixed 
with a formaldehyde solution (Clonetics Corp., Rockland, ME).  A solvent solution 
containing acetic acid and ethanol (Clonetics Corp., Rockland, ME) was then added to the 
cells to allow the release of the NR dye.  Finally, the absorbance at 540 nm for each well was 
determined spectrophotometrically by using a Molecular Devices (Sunnyvale, CA) Thermo 
Max microplate reader. To calculate the percent viability of the treatment groups the average 
absorbance of the treated cells for each dose is divided by the average absorbance of its 
negative control (KGM alone).  Percent viability curves were drawn by plotting the extract 
concentration on the abscissa versus the percent viability on the ordinate using the Prism 
software package version 4.0 (Graphpad Corp., San Diego, CA).  A non-linear regression 
model was then used to fit each viability curve.  None of the data points from any set 
deviated significantly from the model as assessed by the runs test.  The LC50 values are 
interpolated by using the best-fit curve from each treatment as a standard curve.  For all 
experiments 6 replicates per dose group were used per plate (n = 3).   
    Reduction of the yellow colored tetrazolium salt MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to purple colored formazan crystals is indicative of activity of 
mitochondrial reductase enzymes (Mosmann, 1983).  Thus the MTT assay can be categorized 
as a functional cytotoxicity test when using the categorization proposed by Cook and 
Mitchell (1989).  To assess cell viability using the MTT assay the BEAS-2B cells were 
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seeded onto 96-well microtiter plates at a density of 5000 cells/well and allowed to grow 
overnight.  The following day the cells were washed with 1X PBS and exposed for 4 or 24 h 
to iAs3+ or DMAs3+.  After the incubation period the arsenicals were removed, the cells were 
washed twice with PBS and incubated with MTT (1 mg/ml) at 37°C and 5% CO2 for 3h.  
After the incubation period the MTT was removed and the cells washed once with PBS.  The 
formazan crystals were then solubilized by the addition of dimethylsulfoxide (DMSO) to the 
wells.  The absorbance at 550 nm for each well was determined spectrophotometrically by 
using a Bio-Tek Instruments (Winooski, VT) ELx808iu microplate reader.  To calculate cell 
viability we used the same procedure described above for the neutral red assay.  We used 4 
replicates per dose group per plate (n = 3).       
    To perform the clonal expansion assay the BEAS-2B cells were seeded onto 100 mm 
dishes at a density of 10 cells/cm2 and allowed to settle on the plate overnight.  The following 
morning the cells were exposed to iAs3+ or DMAs3+ in KGM for 4 h.  Following the 
exposure the media with arsenic was removed and the cells gently washed twice with PBS.  
The cells were then allowed to grow for approximately 9-10 days in fresh KGM.  After the 
growth period the KGM was removed and the cells washed once with PBS.  The colonies 
were stained with a 0.25% crystal violet (Sigma, St. Louis, MO) solution (containing 10% 
formalin in 80% methanol) for 15 min.  The plates were then washed by submerging them in 
water.  The colonies that had more than 50 cells were considered viable and used for our 
calculations.  Colonies with <50 cells were also counted but not used in the calculations.  To 
calculate arsenic-induced effects on cell growth, a reflection of viability, we used the same 
method as with the neutral red assay but using colony numbers instead of absorbance 
measurements.  For each dose tested we used 3 replicate plates.     
 29 
    The trypan blue (Gibco, Frederick, MD) dye exclusion assay was also utilized to examine 
cell viability; the dye (0.1%) was added to cultures after exposure, cells examined by 
standard light microscopy, and the percentage of cells in a well excluding the dye estimated 
within 5 min.     
 
Interleukin-8 determination.  BEAS-2B cells were seeded onto 24-well plates and exposed 
for 24 h to iAs3+ or DMAs3+ when 95% confluent.  The media supernatant was then collected 
and the presence of IL-8 determined by using Quantikine ELISA kits (R & D Systems, 
Minneapolis, MN), which are based on the quantitative sandwich enzyme immunoassay 
technique.  Fifty microliters of an appropriate standard (supplied by the kit) or sample were 
pipetted into a microtiter plate whose wells are pre-coated with a monoclonal antibody 
specific for IL-8.  Subsequently, 100 µl of conjugate (an enzyme-linked polyclonal antibody 
against IL-8) is added to the wells, thus trapping any IL-8 present in the sample.  After 2.5 h. 
incubation at room temperature the plates are washed six times to remove any unbound 
substances and/or antibody-enzyme reagent and 200 µl of a substrate solution is added to the 
wells.  After a 30 min. incubation at room temperature, 50 µl of a stop solution was added to 
the wells (to prevent further color development) and the absorbance read at 450 nm (λ 
correction at 540 or 570 nm) using a Bio-Tek Instruments CERES 900 microplate reader 
(Winooski, VT).  The absorbance measurements are proportional to the amount of IL-8 
present in the sample.   
  
Single cell gel electrophoresis (SCGE).  The SCGE assay (comet assay) is based on the 
principle that damaged DNA (containing single strand breaks, double strand breaks, alkali 
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labile sites) will migrate a greater distance in an electrophoretic field due to a smaller mass.  
This assay was modified from that done by Lee et al. (1996) with BEAS-2B cells, and those 
recommended by Trevigen Inc. (Gaithersburg, MD).  Briefly, a suspension of cells (1500-
2500 in a final volume of 65 µl) in 0.6 % low-melting point agarose was applied onto a 
Trevigen Cometslide (Trevigen, Gaithersburg, MD) and allowed to solidify at 4oC for at least 
15 min.  The slides were then submerged in lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 
mM Trizma Base, 10% DMSO, 1% sodium sarcosinate, 1% Triton X-100, pH = 10) at 4oC 
for 1 h.  Following the lysis the slides were transferred to an electrophoresis gel box filled 
with alkaline electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH >13) and left 
submerged for 15 min at room temperature.  After the 15 min incubation current was applied 
at 25 volts and 300 mA at room temperature for 15 min.  Immediately after the run the slides 
were washed twice in neutralization buffer (0.4 M Trizma base, pH = 7.5) for 5 min each 
time.  The slides were then air dried at room temperature using a fan and stored at 4oC in the 
dark.      
    Fifty microliters of ethidium bromide (2 mg/ml in distilled water) were added to the dried 
slides to stain the DNA.  DNA migration was visualized on a TV monitor through a camera 
coupled fluorescent microscope (Axiovert 10, Carl Zeiss, Inc., Thornwood, NY) with a 
fluorescent light source (excitation filter of 560 nm and emission filter of 515-590 nm) at 
100X magnification.  An image-analyzing program (Image 1, Universal Imaging Co., West 
Chester, PA) was used to quantify the extent of individual DNA damage by measuring the 
stained DNA migration area, DNA length, and average DNA fluorescence intensity (i.e., 
average DNA staining per area).  Approximately 150-200 cells per slide were measured from 
2-3 independent experiments.   
 31 
    For the alkali labile sites experiments the procedure is the same as described above but the 
pH of the electrophoresis buffer is adjusted to 12.  For the comet post-treatment experiments 
the slides were washed with ddH2O after the 1 h incubation in lysis buffer.  Five nanograms 
of proteinase-K (PK) (Sigma, St. Louis, MO) (in 10 µl of 10 mM Tris-HCl, pH = 7.5) or 0.5 
units of E. coli Endonuclease III (EndoIII) (Trevigen, Gaithersburg, MD) (in 10 µl of 1X 
REC Reaction Buffer 4, Trevigen, Gaithersburg, MD) were added to the center of the gel and 
the slides incubated inside a plastic container lined with wet paper towels for 2h at 37oC.  
The slides were then washed with ddH2O and the rest of the comet procedure performed as 
described.    
 
Determination of PARP-1 activity.  To determine whether iAs3+ had any effect on 
poly(ADP-ribose) polymerase activity, which could affect the formation of DNA strand 
breaks, the activity of this enzyme was determined by examining NAD(P)H depletion 
(Nakamura et al., 2003).  Briefly, the BEAS-2B cells were seeded onto 96-well microtiter 
plates (n = 4 per dose) at a density of 5000 cells/well and allowed to grow overnight.  The 
following day the cells were washed with PBS and the assay was performed following the 
protocol described by Nakamura et al (2003).  In our experiments the test agents used were 
iAs3+ or DMAs3+.  We used 3-aminobenzamide (3-AB) (Sigma, St. Louis, MO) as a PARP-1 
inhibitor.  The difference between 3-AB treated and untreated cells indicated NADPH 
depletion attributable to PARP activity. 
 
Abasic site assay.  The apurinic/apyrimidinic (AP) site is one of the most prevalent lesions 
in DNA.  It can be formed by spontaneous depurination or by the cleavage of the N-glycosyl 
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bond by DNA glycosylases during base excision repair.  To assess for the presence of AP 
sites the BEAS-2B cells were seeded onto 100 mm dishes (n = 3 plates per dose) and allowed 
to grow to confluence.  They were then exposed to 10 µM iAs3+ or 1 µM DMAs3+ in KGM 
for 4 h at 37oC.  After the exposure the cells were washed twice with PBS and the cells 
scraped of the plate on ice.  DNA was extracted using the Gentra Systems (Minneapolis, 
MN) Puregene DNA purification system (salt precipitation method).  We followed the 
manufacturer’ s recommendations with the following adjustments:  The lysis buffer and water 
contained 20 mM and 1mM of TEMPO reagent (an antioxidant), respectively.  Also, all 
procedures were carried out with the samples on ice.  The AP site assay was then carried out 
as previously described (Nakamura and Swenberg, 1999).         
 
Cellular accumulation of arsenic.  BEAS-2B cells grown on T-25 flasks (90-95% 
confluent) were exposed to iAs3+ or DMAs3+ for 4 or 24 h at 37oC.  After the exposure the 
cell media was collected and centrifuged to remove any suspended solids.  The cells were 
then washed twice with PBS and incubated with 2 ml of ultrapure distilled water (Milli-Q 
Gradient, Millipore Corporation, Bedford, MA) at 4oC for 1 h.  Distilled water and cells were 
then transferred to washed and tared digestion tubes.  The cell lysates (in distilled water) 
were then digested with 1% tetramethylammonium hydroxide, followed with concentrated 
HNO3 (Optima grade, Fisher Scientific, Pittsburgh, PA) and additional distilled water to a 
volume of 6.8 ml.  The digests were incubated for 1 h at 100oC.   
KGM media samples were equilibrated to room temperature in a clean bench less than 4 
hours prior to inductively coupled plasma-optical emission spectroscopy (ICP-OES) analysis.  
Immediately prior to analysis, all samples were diluted volumetrically with 0.75% HNO3.  
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For the KGM media samples a PerkinElmer 4300DV ICP-OES was used.  The analytical 
wavelengths used were 188.979 and 193.696 nm.  For the cell digests the elemental arsenic 
concentration in the resulting samples was analyzed by background corrected ICP-mass 
spectrometry (Elan 6000, Perkin Elmer, Wellesley, MA) (Olivares, 1988).  All procedures 
were based on EPA Methods 200.11 or 200.7 (U.S. EPA, 1991).            
 
Statistical analysis.  All statistical analyses were performed using the GraphPad Prism 
version 4.0 software package (GraphPad Software Inc., San Diego, CA).  Probability values 
< 0.05 were considered significant.  Statistical analysis for most experiments consisted of 
parametric t-tests unless otherwise indicated.  For cell viability comparisons we used two-
way ANOVA with Bonferroni post-tests.   
 
Results: 
Cell viability.  When using the MTT assay after both 4 and 24 h experiments a decreased 
viability was found at the higher doses utilized.  Statistically significant cytotoxicity in 
cultures exposed to iAs3+ was observed at >100 µM with 4 hr exposures and >10 µM with 24 
h exposures (p<0.05). The LC50 for iAs3+ after 4 and 24 h incubations were 779 µM and 24 
µM, respectively (Fig. 2-1a).  For DMAs3+ exposures, cytotoxicity was observed at >1 and 
>0.01 µM with the 4 and 24 h exposure periods, respectively (p<0.05). The LC50 after 4 and 
24 h incubations are 3 µM and 1.7 µM, respectively (Fig. 2-1b).  Using neutral red uptake (at 
the 24 h exposure time point only), the data was similar to data obtained with the MTT assay 
in that statistically significant increased cytotoxicity was observed at higher concentrations 
though there was a difference quantitatively between the two assays.  For instance, after a 24 
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h incubation of the BEAS-2B cells with iAs3+ and DMAs3+ we determined that the median 
lethal dose (LC50) when using the neutral red dye was 47 µM and 8 µM, respectively. 
    We also evaluated cell proliferation and cytotoxicity using the clonal expansion assay.  
The BEAS-2B cells were exposed to either iAs3+ or DMAs3+ for 4 h and then allowed to 
grow in fresh media without arsenic for approximately 10 days.  At the end of the growth 
period the cells were stained with crystal violet and all colonies with more than 50 cells were 
scored.  We also counted colonies that had fewer than 50 cells for comparison.  The EC50 for 
iAs3+ in the BEAS-2B cells when using the clonal expansion assay was 113 µM (Fig. 2-2a) 
and for DMAs3+ was 5 µM (Fig. 2-2b).  We found that the lowest concentration of iAs3+ (0.1 
µM) induced an increase in colonies (Fig. 2-2a),  but that was nonsignificant.  The 
percentage of colonies of >50 cells was 116 ± 8.7% of control values.  In average control 
cultures have 18.4% of all colonies with <50 cells, while 14.8% of colonies exposed to 0.01 
µM iAs3+ had <50 cells.   No increased cell colonies relative to control were observed with 
cultures exposed to DMAs3+.  If the control cells are allowed to grow for an extra 24 h the 
percent of small colonies drops to 8.1, indicating that control cultures had not stopped 
proliferating.  As a reference, H2O2 exposure decreased colony formation at concentrations 
>5 µM.   
    We also performed observations by standard light microscopic technique of arsenic-
induced cytotoxicty by qualitatively examining cell morphology and trypan blue dye 
exclusion at the 10 µM iAs3+ and the 1 µM DMAs3+ concentrations.  At these doses the 
BEAS-2B cells appear to be >90% viable after 4 h and no significant detachment or other 
gross morphological changes are observed. 
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Assessment of arsenic uptake.  We exposed the BEAS-2B cells to various concentrations of 
iAs3+ or DMAs3+ for 4 or 24 h.  After the exposure, we quantified the amount of arsenic (not 
speciated) in the cell media and cell-associated by ICP-MS analysis. After 4 h the BEAS-2B 
cells take up roughly 0.6% of the iAs3+ when exposed to either 1 or 10 µM (Table 2-1).  
After 24 h, the amount of As inside the cells remained at roughly 0.6% of the exposure 
concentration.  Arsenic was not detected in cells incubated with 0 or 0.1 µM iAs3+ for 4 or 24 
h.   In contrast, after a 4 h exposure of the cells to 1 µM DMAs3+, the cell-associated arsenic 
content is approximately 18% of the exposure concentration.  When the DMAs3+ exposure is 
increased to 10 µM, the cells take up approximately 8.6% of the arsenic dose to which they 
were exposed.  After a 24 h exposure to 1 and 10 µM DMAs3+, the BEAS-2B cell-associated 
arsenic content decreased (from 4 h values) to 6.7 and 7.5% of the exposure concentration, 
respectively. 
 
IL-8 release.  We evaluated IL-8 release by the BEAS-2B cells after exposing the cells to 
both arsenic compounds for 24 h.  Sodium arsenite exposure induced a significant (p < 0.05) 
increase of IL-8 release by the BEAS-2B cells at 25 µM, 50 µM, and 100 µM  (Fig. 2-3).    
Interleukin-8 release after DMAs3+ exposure was significant only at the 5 µM DMAs3+ 
exposure (Fig. 2-3).      
 
SCGE assay of iAs3+ and DMAs3+.  After a 4 h incubation of the BEAS-2B cells with 
varying concentrations of iAs3+ (up to 10 µM) at 37oC we did not find any significant 
difference in DNA area between the treated (means between 419 – 440 µm2) and control 
cells (mean of 382 µm2) (Fig. 2-4).  However, the 1 µM dose of iAs3+ did had a significant 
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increase in DNA area (475 µm2, p = 0.05) when compared to the control cells.  In order to 
assess whether our cell media (KGM) was suppressing iAs3+-induced effects, we incubated 
the cells with iAs3+ in PBS for 1 and 4 h at 37oC, but also found no increase in DNA area.  
We also incubated the BEAS-2B cells with iAs3+ in PBS for 1 h at 4oC in order to increase 
the sensitivity of the assay by suppressing enzymatic activity (e.g., DNA repair and 
antioxidant enzymes).  However, we also found no increase in DNA area when compared to 
control levels.  It is important to note that only during the initial experiment at 37oC did we 
find that 1 µM iAs3+ caused a statistically significant increase in DNA area.  This finding was 
not replicated in several subsequent studies.  
    After a 4 h incubation of the BEAS-2B cells with DMAs3+ (Fig. 2-5), there was a 
significant increase in DNA area with exposures to 1 µM, 5 µM, and 10 µM DMAs3+ (468 
µm2, 651 µm2, 788 µm2; p <0.05) when compared to control cells (382 µm2).  The effect of 
the alkylating agent MMS on the BEAS-2B cells after a 4 h exposure was determined.  An 
exposure to 2 mM MMS increased DNA area to >1500 µm2.      
    To determine whether the increase in DNA damage after DMAs3+ exposure could be 
partly explained by the generation of alkali labile sites, BEAS-2B cells were exposed for 4 h 
to 1 and 10 µM DMAs3+ and then the SCGE assay was done at pH = 12 and 13 (Fig. 2-6). 
The DNA area at pH = 12 and 13 were similar after exposure of the BEAS-2B cells to 
DMAs3+, i.e., there were no significant differences at 0 and 1µM DMAs3+ (Fig. 2-6).  At 10 
µM DMAs3+ the DNA area at pH = 12 was 695 µm2 and at pH = 13 it was 762 µm2.  
    To assess whether the formation of DNA-protein crosslinks were affecting DNA migration 
in the SCGE assay, BEAS-2B cells were exposed for 4 h to 10 µM iAs3+ and then the 
agarose-embedded cells already mounted on the slides and lysed were treated with 5 ng of 
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PK for 2 h to degrade DNA-protein cross-links.  PK treatment did not increase the DNA area 
in BEAS-2B cells previously exposed to iAs3+ or media alone (Fig. 2-7). 
    To assess whether iAs3+ treatment was generating pyrimidine DNA adducts excisable by 
E. coli EndoIII, cells were exposed to 10 µM iAs3+ for 4 h and then the agarose-embedded 
cells already mounted on the slides and lysed were treated with 0.5 units of EndoIII for 2 h.  
We found no statistical difference in DNA area between the control or iAs3+ treated cells 
exposed to Endo III (Fig. 2-7).  Additionally treatment of cells exposed to 0 or 10 µM iAs3+ 
with both the PK and Endo III simultaneously did not show statistically significant 
differences in DNA area among any groups (Fig. 2-7).    
    Potentially iAs3+ may have inhibited poly(ADP-ribose) polymerase (PARP) activity 
(Hartwig et al., 2003), thus inhibiting repair of DNA and decreasing strand break sites.  To 
examine whether PARP activity was affected by iAs3+ or DMAs3+ after 4 h exposures, an 
assay that indirectly monitors PARP-1 activation via the depletion of NAD(P)H was 
employed (Nakamura et al., 2003).  BEAS-2B cells were exposed to iAs3+ (0.1 nM – 10 µM) 
or DMAs3+ (1 nM – 50 µM) for up to 4 h while the depletion of NAD(P)H was monitored.  
The data showed that PARP-1 activity in iAs3+ or DMAs3+ exposed cells was similar to 
vehicle-treated cells at all time points examined (data not shown).  
 
Abasic sites.  After exposing the BEAS-2B cells to iAs3+ and DMAs3+ we found no 
statistically significant differences in AP sites between the cells exposed to 10 µM iAs3+ 
(2.38 AP sites/106 nucleotides) vs. the control cells exposed to KGM alone (2.30 AP sites/106 
nucleotides).  We also did not find any statistically significant differences between the 
control cells and those exposed to 1 µM DMAs3+ (2.18 AP sites/106 nucleotides).   
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Discussion: 
    The purpose of this study was to evaluate the cytotoxicity and DNA damage induced by 
inorganic and organic arsenic compounds in a human bronchial epithelial cell line.  The data 
suggest that DMAs3+ was more cytotoxic than iAs3+ in all three cytotoxicity assays used 
(Figs. 2-1 and 2-2).  Although arsenic methylation has been traditionally viewed as a 
detoxification pathway (IPCS, 2001, section 6.1), several studies provide evidence that 
methylated arsenic metabolites can be more cytotoxic (Styblo et al., 2002) and genotoxic 
(Mass et al., 2001) than iAs3+, particularly DMAs+3.  In humans arsenic accumulates 
primarily in hair and urine, followed by the skin and lungs, and lastly in fluids and other 
tissues (Yamauchi and Yamamura, 1983).  Human bronchial epithelial cells incubated with 
0.05 µM iAs+3 for 24h methylate ~1% of the available arsenic (to MAs).  Differentiated 
bronchial cells exposed to 0.05 µM iAs+3 for 48h produce MAs and DMAs representing 
2.8% and 0.5% of the total arsenic (Styblo et al., 2000).  These results suggest that arsenic 
metabolism in lung cells is minimal, though this may be due to a small number of individual 
donors examined or due to cell culture conditions.  However, in animals it has been shown 
that DMAs3+ accumulates in the lungs, possibly because this organ is an excretory pathway 
for gaseous dimethylarsine (Yamanaka et al., 2004).  Though not statistically significant, the 
data suggested that exposure to 0.1 µM iAs3+ induced an increased cell proliferation rate in 
the BEAS-2B cells.  This finding is consistent with those found in other cell types such as rat 
lung epithelial cells (Lau et al., 2004) or human epidermal cells (Patterson et al., 2005), and 
may suggest a mechanism for arsenic-induced lung carcinogenesis (Kitchin, 2001). 
    The alkaline SCGE assay can detect DNA single strand breaks in individual cells.  It can 
also detect alkali labile sites (abasic sites turned strand breaks by the alkaline treatment) 
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when using highly alkaline conditions, i.e., pH > 13.  The data show that sub-toxic doses of 
iAs3+ by itself do not induce an increase in DNA area (DNA damage as measured by the 
standard SCGE assay) after 4 h exposures of the BEAS-2B cells at both 4o and 37oC.  
However DMAs3+ at 5 µM (sub-toxic) and 10 µM (toxic concentrations in the MTT assay) 
can induce an increase in DNA area after a 4 h exposure at 37oC.  We also found that 1 µM 
iAs3+ or DMAs3+ did induce significant increases in DNA area.  However, these increases 
were relatively small, and were not replicable in subsequent experiments.     
    The results presented here are consistent with the findings of Wang et al. (2001) where the 
SCGE assay fails to detect iAs3+-induced DNA damage.  However, it is also possible that the 
BEAS-2B cell line is more resistant to DNA damage than other cell types.  In order to assess 
whether DNA-protein crosslinking could be leading to an underestimation of our iAs3+ 
results we decided to treat our SCGE slides with PK but found no significant differences 
when comparing to the control cells.  We also decided to test whether alkali labile sites 
comprise a significant portion of the DNA damage detected by performing the assay at pH = 
12. There is no significant change in DMAs3+ treated cells DNA damage suggesting the 
absence of DNA alkali labile sites.   
    Previous studies have shown that inorganic arsenic-induced DNA damage, as assessed by 
the comet assay, varies across cell types and procedures used.  For example, up to 30 µM 
sodium arsenite exposure induced increased DNA damage detected by the SCGE assay in 
human lung fibroblasts (MRC-5) (Mouron et al. (2005);  rainbow trout gonad-2 (RTG-2) and 
Chinese hamster ovary-K1 (CHO-K1) lines (Raisuddin and Jha (2004), lymphoblastoid cell 
line (TK6) (Guillamet et al. (2004)), and also murine keratinocytes (JB6) (Shi et al. (2004) ).  
In this latter study, using a variety of antioxidant compounds the authors reach the conclusion 
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that the DNA damage induced by arsenic is caused by hydroxyl radical formation. Despite 
the preceding findings, arsenite exposure may produce too few DNA lesions to be detected 
by the standard SCGE assay (Wang et al., 2001; Rossman et al., 2003).  For example, Mass 
et al. (2001) found that neither arsenite nor arsenate induces significant increased DNA 
strand breaks in human lymphocytes assessed in the SCGE assay.  However, Wang et al. 
(2001) demonstrated that using PK and Fpg comet post-treatments increases the amount of 
DNA lesions detected in the human leukemia cell line (NB4) upon 0.25 µM iAs3+ treatment.  
Taken together these results seem to indicate that DNA lesions after arsenite exposure are 
highly variable depending on the cell type analyzed and the assay conditions used. 
    As discussed in the introduction, recent reports in the literature suggest that organic 
trivalent arsenicals can be more genotoxic and cytotoxic than inorganic arsenic compounds.  
One such study reports that methyloxoarsine (MAs3+) and iododimethylarsine (DMAs3+) are 
more potent than iAs3+ in inducing DNA lesions detectable by SCGE after exposing human 
lymphocytes for two hours, and induce direct lesions in φX174 DNA (Mass et al., 2001).  
Moreover, Nesnow et al. (2002) demonstrated that MAs3+ and DMAs3+ lesions in supercoiled 
φX174 DNA are caused by reactive oxygen species.  However, it is important to note that 
Wang et al. (2002) found that after enzymatic treatment of comet assay slides arsenite 
induced more lesions than MAs3+ in HL-60 cells (using doses of 0.1 and 1µM).  Without 
enzyme treatment MAs3+ was more potent than iAs3+ (DMAs3+ was not evaluated).  The 
authors also report that iAs3+ induced more EndoIII digestible adducts (which removes 
oxidized pyrimidines) and MAs3+ induced more PK digestible adducts.  The authors suggest 
that organic and inorganic arsenicals have different mechanisms of DNA damage induction 
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and suggest that peroxynitrite, hypochlorous acid, and hydroxyl radicals are involved in iAs3+ 
induced DNA lesions whereas peroxyl radical is involved in MAs3+ induced DNA lesions. 
    Another factor that might potentially explain the increased DNA damage and cytotoxicity 
induced by DMAs3+ relative to iAs3+ is the differential accumulation by the cells of both 
arsenic species.  After a 4 h or a 24 h incubation with 1 and 10 µM iAs3+ the BEAS-2B cells 
take-up <1% of the elemental arsenic to which they were exposed (Table 2-1).  On the 
contrary, the cells exposed to 1 µM DMAs3+ for 4 h take-up approximately 18% of the 
elemental arsenic to which they were exposed (Table 2-2).  The cells exposed to 10 µM 
DMAs3+ for 4 h, and 1 and 10 µM DMAs3+ for 24 h had decreased uptake (6-9%).  This 
decreased uptake of elemental arsenic at the 10 µM exposure after 4 h might be due to 
cytotoxicity.  In terms of mass the amount of elemental As found inside the cells is larger in 
the 1 µM DMAs3+ group (124.5 ng) vs. the 10 µM iAs3+ group (54.9 ng).  These results 
suggest that increased accumulation of organic arsenicals might partly explain their 
genotoxicity.  It remains to be determined whether As transport proteins might play a role in 
this relationship.        
    We further evaluated whether iAs3+ or DMAs3+ had any effect on PARP-1 activity after 4 
h exposures.  PARP-1 is an accessory protein of the base excision repair pathway.  It has 
been shown that very low doses or iAs3+ can inhibit the activity of this enzyme in cultured 
HeLa cells after 18 h exposures (Hartwig et al., 2003).  Using the NAD(P)H assay we did not 
find any decrease of PARP-1 by iAs3+, however, our exposures were for 4 h and more time 
may be necessary for any effect to be detectable.  We also evaluated whether iAs3+ or 
DMAs3+ could be inducing AP sites undetectable with the SCGE assay.  AP sites can be 
formed by spontaneous depurination or by the cleavage of the N-glycosyl bond by DNA 
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glycosylases during base excision repair (Nakamura and Swenberg, 1999).  We did not find 
any statistically significant differences in the amount of AP sites present in the control or 
iAs3+ and DMAs3+ treated cells.  This finding could be partly explained by differential 
activity (increased or decreased) of BER enzymes on the BEAS-2B cells after iAs3+ 
exposure.  
    Taken together our results provide support to the hypothesis that trivalent organic 
arsenicals are more cytotoxic and genotoxic than inorganic arsenicals.  This finding is 
important given that DMAs3+ accumulates in the lungs of animals.  We also found that 
DMAs3+ could induce DNA damage by itself in the SCGE assay whereas iAs3+ did not.  This 
finding is also similar to literature reports.  However, the lack of DNA single strand break 
damage induced by iAs3+ requires further analysis of the mechanism of iAs3+-induced lung 
cancer. In order to clarify this issue, different techniques examining DNA damage may need 
to be utilized.   
    Also to be considered is what role iAs3+ exposure has on inducing oxidative stress in lung 
cells in vivo via indirect cellular mechanisms and also in response to other pollutants.  In this 
report, the data suggest that this arsenic species may participate in inducing a neutrophil 
influx via an increased production of the neutrophil chemotaxin IL-8.  Generally neutrophils 
that migrate to the airways are in an activated state, producing ROS such as H2O2. Reports 
have shown a rat lung neutrophilia upon intratracheal instillation of iAs3+ (Lantz et al., 1995), 
and lung inflammation (i.e., bronchiectasis determined by CT scan) in humans exposed to 
high concentrations of arsenite in drinking water (Mazumder et al, 2005).  The effects of 
arsenic species on H2O2-mediated DNA and cellular damage to airway epithelial cells 
remains to be ascertained. 
 43 
Acknowledgements: 
The authors thank Lisa Dailey and Jackie Stonehuerner for technical assistance.  AM 
supported by EPA/UNC CT827206 and NIEHS T32-07126. 
 
 
 
 
 44 
Figure Legends: 
Figure 2-1.  Viability via the MTT assay of the BEAS-2B cells after 4 and 24 h incubations 
with iAs3+ (A) or DMAs3+ (B).  The LC50 for iAs3+ after 4 h was 779 µM (The r2 value for the 
nonlinear regression used to calculate the LC50 was 0.7856, df = 13).  The LC50 for iAs3+ 
after 24 h was 24 µM (The r2 value for the nonlinear regression used to calculate the LC50 
was 0.9309, df = 11).  The LC50 for DMAs3+ after 4 h was 3 µM (The r2 value for the 
nonlinear regression used to calculate the LC50 was 0.9450, df = 12).  The LC50 for DMAs3+ 
after 24 h was 1.7 µM (The r2 value for the nonlinear regression used to calculate the LC50 
was 0.7678, df = 11).  (* = p < 0.05 when compared to control).   
 
Figure 2-2.  Viability via the clonal expansion assay of the BEAS-2B cells after 4 h 
incubations with iAs3+ (A) or DMAs3+ (B).  The EC50 for iAs3+ after 4 h was 113 µM (The r2 
value for the nonlinear regression used to calculate the EC50 was 0.9424, df = 14).  The EC50 
for DMAs3+ after 4 h was 5 µM (The r2 value for the nonlinear regression used to calculate 
the EC50 was 0.8724, df = 16).  (* = p < 0.05 when compared to control).   
 
Figure 2-3.  IL-8 release by the BEAS-2B cells after 24 h exposures to iAs3+ or DMAs3+.  
The IL-8 values at 25, 50, and 100 µM iAs3+ are significantly different to the control (# p < 
0.05).  The IL-8 value at 5 µM DMAs3+ was significantly different to the control (* p < 
0.05). 
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Figure 2-4.  DNA breaks sustained by the BEAS-2B cells after a 4 h exposure to iAs3+.  An 
increase in DNA area represents an increase in DNA strand breaks.  (* p < 0.05) (n = 2 
independent experiments with ~200 observations each).   
 
Figure 2-5.  DNA breaks sustained by the BEAS-2B cells after a 4 h exposure to DMAs3+.  
An increase in DNA area represents an increase in DNA double strand breaks (DSBs) and 
single strand breaks (SSBs).  (* p<0.05) (n = 2-4 independent experiments with ~200 
observations each).   
 
Figure 2-6.  Assessment of DNA alkali labile sites in BEAS-2B cells after a 4 h exposure to 
DMAs3+.  SCGE assay was performed on cells at pH 12 and pH 13. An increase in DNA area 
represents an increase in DNA strand breaks  (* p<0.05) (n = 2 independent experiments with 
~200 observations each).  
 
Figure 2-7.  DNA breaks sustained by the BEAS-2B cells after a 4 h exposure to iAs3+ and 
subsequent treatment of the lysed agarose-embedded cells with 5 ng PK, or 0.5 units of Endo 
III, or a combination of both.  (n = 2 independent experiments with ~200 observations each). 
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Figure 2-1a 
 
 
 
0.01 0.1 1 10 100 1000 10000
0
25
50
75
100
125
150
24H
4H
LC50 4h = 779 µM
LC50 24h = 24 µM
*
*
*
iAs3+ (µM)
Vi
ab
ili
ty
 
(%
 
Co
n
tr
o
l)
 
 
 
 
 
 
 
 
 
 
 
 
 
 49 
 
Figure 2-1b 
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Figure 2-2a 
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Figure 2-2b 
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Figure 2-3 
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Figure 2-7 
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Abstract: 
    The lungs are a target organ for arsenic-induced carcinogenesis, however, its mechanism 
of action remains unclear.  It has been suggested that inorganic arsenic (iAs3+) can potentiate 
DNA damage induced by other agents.  To study the possible mechanistic link between 
arsenic and lung carcinogenesis we examined whether trivalent organic arsenic and iAs3+ 
could modify DNA damage caused by the endogenous oxidant hydrogen peroxide (H2O2).  
BEAS-2B cells (immortalized from human bronchial epithelium) were pre-treated with iAs3+ 
or dimethylarsine iodide (DMAs3+) for 4 h, and then exposed to 20 M H2O2 for 30 min. at 
4oC.  We found that H2O2-exposed cells that were pre-treated with iAs3+ (at 10 M) and 
DMAs3+ (at 1 and 10 M) had a statistically significant increase (p < 0.05) in DNA damage 
(as assessed by alkaline single cell gel electrophoresis) when compared to H2O2-exposed 
control cells (pre-treated with 0 M H2O2) suggesting that these arsenicals sensitize cells to 
oxidant-induced damage.  Recently it has been suggested that the activity of the divalent 
metal transporter-1 (DMT1), which participates in the metabolism of iron to decrease cellular 
oxidative stress, can be modulated by exposure to metals.  To further test whether arsenicals 
can alter iron metabolism via downregulation of DMT1 activity and increase DNA damage, 
we exposed BEAS-2B cells to iAs3+ and DMAs3+ for 4h.  As a comparison, cells were also 
incubated with ferric ammonium citrate (FAC) or vanadyl sulfate (VOSO4) (which 
upregulate and downregulate DMT1 expression and activity, respectively).  Twenty hours 
later the cells were washed and exposed to 100 µM FAC with or without 20 µM H2O2 for 30 
min.  Cells pre-treated with VOSO4 and subsequently exposed to both FAC and H2O2 had a 
statistically significant (p < 0.05) increase in DNA damage when compared to control cells 
pre-treated with cell media alone.  Cells that were pre-treated with FAC, iAs3+, or  DMAs3+ 
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did not have altered DNA damage compared to the control cells.  The data suggest that 
VOSO4–induced alteration of iron metabolism induces oxidative stress as evidenced by 
increased DNA damage, but that iAs3+ and DMA3+ did not induce lung cell oxidative stress 
in a similar fashion.  
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Introduction: 
    Epidemiological studies have linked the inhalation of airborne particulate matter (PM) to 
increased morbidity and mortality in humans (US EPA, 2004).  Toxicological studies in 
rodent models link particle exposure to pulmonary inflammation, decreased pulmonary 
defense and increased airway hyperresponsiveness (US EPA, 2004).  Similar findings have 
been reported in controlled exposures of human subjects to ambient PM that is either 
intratracheally instilled or concentrated over background levels and inhaled by subjects (Ghio 
and Devlin, 2001).  Ambient PM mass concentrations have been reported to be associated 
with increased lung cancer incidence (Pope et al., 2002).  Metals may play an important role 
in the toxicity of airborne particulate matter, possibly via generation of reactive oxygen 
species (ROS) (Frampton et al., 1999).  ROS can react with macromolecules thus affecting 
cellular function. 
    The lungs are one of the most important target organs for carcinogenicity associated with 
arsenic exposure (IPCS, 2001, sections 7.1.7 and 8.7).  Humans can be exposed to this semi-
metal via drinking water, food, or air (where it is primarily bound to particulate matter) 
(IPCS, 2001, section 5.2.1).  Several hypotheses have been suggested to explain the 
carcinogenic mode of action for arsenic.  Some of these include the induction of oxidative 
stress and inhibition of DNA repair (Kitchin, 2001).  Not all forms of arsenic species are 
equally potent.  While humans are primarily exposed to the inorganic forms of arsenic via 
drinking water, once inside the human body inorganic arsenicals undergo a series of redox 
and methylation reactions (Thomas et al., 2001; Styblo et al., 2002).  Recent studies suggest 
that methylated forms of trivalent arsenic can be more cytotoxic and induce more DNA 
damage than the inorganic forms (Mass et al., 2001; Styblo et al., 2002).   
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    Arsenic exposure has been shown to induce additive and synergistic effects with other 
substances.  For instance, it has also been shown in hepatic cell cultures that arsenic is 
capable of potentiating the effects of other carcinogens, e.g.,  benzo[a]pyrene, a contaminant 
whose ubiquitous presence in the atmosphere and in cigarette smoke makes it a relevant 
human risk (Maier et al., 2002).  Moreover, lung cancer risk among smokers who have been 
occupationally exposed to arsenic have shown from additive to synergistic interactions 
(Pershagen et al, 1981; Jarup & Pershagen, 1991; Hertz-Picciotto et al., 1992).  It has also 
been shown that arsenic can act as a skin co-carcinogen with UV light in a mouse model 
(Burns et al., 2004).  Jha and collaborators (1992) showed that iAs3+ when given in 
conjunction with X-rays and UV light induced an increase in chromosomal aberrations in 
human fibroblasts.  Wiencke & Yager (1992) demonstrated that the DNA crosslinking agent 
diepoxybutane potentiates chromosomal aberrations in lymphocytes after iAs3+ exposure.  
Hartwig and collaborators (2003) suggest that PARP inhibition after incubation of HeLa cells 
with concentrations as low as 10 nM iAs+3 for 18 h lead to increased sensitivity to H2O2 
induced oxidative damage.  It has also been proposed that arsenic can act in conjunction with 
other metals (e.g. Cd) to cause DNA repair inhibition and DNA damage (Hartwig & 
Schwerdtle, 2002).  Finally, Sturlan et al. (2003) found that arsenic trioxide can react with 
docosahexaenoic acid producing reactive oxygen species and lipid peroxidation. 
    Iron is typically the predominant transition metal found on ambient airborne PM (US EPA, 
2004).  The metabolism of iron upon deposition in the lung can be important in responses 
such as oxidative stress of pulmonary cells to this metal.  The divalent metal transporter-1 
(DMT1) is a membrane protein that is primarily present in gastrointestinal and lung cells.  
DMT1 transports divalent metal cations inside the cells by a proton gradient.  It has been 
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shown to transport as many as eight different metals including Fe, Cu, Ni, Zn, and Cd 
(Garrick et al., 2003).  It has recently been suggested that DMT1 might participate in the 
detoxification of metals that can damage lung epithelium.  Elevated extracellular iron levels 
in vitro increase the expression and activity of DMT1 in BEAS-2B cells (a bronchial 
epithelial cell line) stimulating iron uptake and storage in ferritin.  This would make iron 
unavailable to participate in the generation of extracellular reactive oxygen species (ROS) 
(Ghio et al., 2005).  Moreover, it has been reported that vanadium exposure can 
downregulate DMT1 expression and activity, thus sensitizing cells to oxidative damage 
induced by a subsequent ferrous iron exposure (Ghio et al, 2005).        
    The purpose of our studies is to examine the effect that exposure to iron, vanadium, and 
arsenic compounds have on oxidative DNA damage induced by hydrogen peroxide (H2O2). 
H2O2 is produced constitutively by most lung cells, and H2O2 formation is increased by 
inflammatory cells such as macrophages and neutrophils after exposure to airborne 
particulate matter and other stimulants (Ward et al., 1986).  H2O2 is also formed by chemical 
reactions between ozone and lung lining constituents (Madden et al., 1993).  It has been 
shown that elevated levels of H2O2 are present in exhaled breath condensate (EBC) of 
pneumonia patients (Majewska et al., 2004) and EBC of ozone-exposed subjects (Madden et 
al, 1997).  Moreover, exposure of primary human airway epithelial cells to H2O2 induces an 
increase in interleukin-8 and mitogen-activated protein kinases (Pelaia et al., 2004).        
    We also evaluated what role the metal transporter DMT1 might play in modifying DNA 
damage when its expression is changed by metal or semi-metal (e.g., arsenical) pre-
treatment.  The results from these experiments will yield information on whether any of these 
compounds can act as co-carcinogens with H2O2.  We have not found literature reports 
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dealing with DNA damage induced by any of these agents together with H2O2 in human 
bronchial epithelial cells.      
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Methods: 
Cell culture, chemicals, and in vitro exposures.  BEAS-2B cells (S6 subclone; passages 
72-95) were obtained courtesy of Drs. Curtis Harris and John Lechner from the National 
Institutes of Health (Reddel et al., 1988).  This is an immortalized line of normal human 
bronchial epithelium.  The cell media used was Clonetics (Rockland, ME) keratinocyte 
growth medium (KGM), which is essentially MCDB 153 medium supplemented with 5 
ng/ml human epidermal growth factor, 5 mg/ml insulin, 0.5 mg/ml hydrocortisone, 4 ml/L 
bovine pituitary extract, and 0.5 ml of GA-1000.  All cells were grown at 37°C and 5% CO2 
with fresh media being added every other day.  When cells reached 95% confluence they 
were split, counted, and seeded onto tissue culture plates.  Upon reaching 95% confluence 
the cells were then exposed to freshly prepared sodium arsenite (iAs3+) (Sigma, St. Louis, 
MO) or dimethylarsine iodide (DMAs3+) that was synthesized by Dr. William R. Cullen 
(University of British Columbia, Vancouver, Canada) using previously described methods 
(Cullen et al., 1984 and Styblo et al., 1997). Both arsenicals were dissolved in KGM for the 
exposures.  We also exposed the cells to ferric ammonium citrate (FAC or Fe3+) (Aldrich, 
Milwaukee, WI) or vanadium (IV) sulfate oxide (VOSO4 or V4+) (Alfa Aesar, Ward Hill, 
MA) that were dissolved in KGM.  After the initial exposures the cells were rinsed twice 
with phosphate buffered saline (PBS) (Gibco, Frederick, MD) and exposed to H2O2 (Sigma, 
St. Louis, MO) dissolved in PBS for 30 min.  All metal and As solutions were prepared fresh 
(from solid stocks) the same day of the experiment.  Working solutions of H2O2 were also 
prepared fresh from 30% stock bottles immediately before it was added to the cells.  In some 
experiments we also supplemented the H2O2 with 100 µM FAC.  All other chemicals used 
were purchased from Sigma Corp. (St. Louis, MO) unless otherwise noted.     
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Single cell gel electrophoresis (SCGE).  The SCGE assay (comet assay) is based on the 
principle that damaged DNA (containing single strand breaks, double strand breaks, alkali 
labile sites) will migrate a greater distance in an electrophoretic field due to a smaller mass.  
The protocol used for performing this assay was modified from that done by Lee et al. (1996) 
and those recommended by Trevigen Inc. (Gaithersburg, MD).  Briefly, a suspension of cells 
(1500-2500 in a final volume of 65 µl) in 0.6 % low-melting point agarose was applied onto 
a Trevigen Cometslide (Trevigen, Gaithersburg, MD) and allowed to solidify at 4oC for at 
least 15 min.  The slides were then submerged in lysis buffer (2.5 M NaCl, 100 mM EDTA, 
10 mM Trizma Base, 10% DMSO, 1% sodium sarcosinate, 1% Triton X-100, pH = 10) at 
4oC for 1 h.  Following the lysis the slides were transferred to an electrophoresis gel box 
filled with alkaline electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH >13) and left 
submerged for 15 min at room temperature.  After the 15 min incubation, current was applied 
at 25 volts and 300 mA at room temperature for 15 min.  Immediately after the run the slides 
were washed twice in neutralization buffer (0.4 M Trizma base, pH = 7.5) for 5 min each 
time.  The slides were then air dried at room temperature using a fan and stored at 4oC in the 
dark.      
    Fifty microliters of ethidium bromide (2 mg/ml in distilled water) were added to the dried 
slides to stain the DNA.  DNA migration was visualized on a TV monitor through a camera 
coupled fluorescent microscope (Axiovert 10, Carl Zeiss, Inc., Thornwood, NY) with a 
fluorescent light source (excitation filter of 560 nm and emission filter of 515-590 nm) at 
100X magnification.  An image-analyzing program (Image 1, Universal Imaging Co., West 
Chester, PA) was used to quantify the extent of individual DNA damage by measuring the 
stained DNA migration area, DNA length, and average DNA fluorescence intensity (i.e., 
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average DNA staining per area).  Approximately 150-200 cells per slide were measured from 
2-3 independent experiments.   
 
Measurement of thiobarbituric acid reactive substances (TBARS).  The oxidative 
potential of iAs3+ and DMAs3+ was assessed by means of the TBARS assay (Halliwell and 
Gutteridge, 1981).  This assay is based on the principle that any test substance that can 
sustain a redox cycle will drive the reaction of H2O2 or other ROS and deoxyribose, 
producing malondialdehyde (MDA).  MDA can then be measured by adding thiobarbituric 
acid (TBA) to the sample, as these two substances react forming an adduct whose absorbance 
can be measured by spectrophotometry.  Solutions of 1 and 10 µM iAs3+ or DMAs3+ were 
prepared in PBS.  As a positive control we included a sample containing 100 µg/ml DOFA, 
an oil fly ash collected from a boiler from Durham, NC.  DOFA is an iron rich particulate 
(Ghio et al., 2002).  All experiments were done in triplicate.  Once prepared the samples were 
agitated for 1 hour at 37oC in the presence of 1 mM each of 2-deoxy-D-ribose, sodium 
ascorbate, and H2O2 (Ghio et al., 1994).  The suspensions were then centrifuged for 10 min. 
at 1300 x g, after which 1.0 ml of the supernatant was mixed with 2 ml of 5 mg/ml 2-
thiobarbituric acid and 14 mg/ml trichloroacetic acid in water.  The samples were then heated 
10 minutes at 100oC and cooled in an ice bath.  The absorbance of the samples was read at 
532 nm on a Beckman DU640B spectrophotometer (Fullerton, CA).   
 
Abasic site assay.  The apurinic/apyrimidinic (AP) site is one of the most prevalent lesions 
in DNA.  It can be formed by spontaneous depurination or by the cleavage of the N-glycosyl 
bond by DNA glycosylases during base excision repair.  To assess for the presence of AP 
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sites the BEAS-2B cells were seeded onto 100 mm dishes and allowed to grow to 95% 
confluence.  They were then exposed as described and DNA extracted using the Gentra 
Systems (Minneapolis, MN) Puregene DNA purification system (salt precipitation method) 
at the end of the exposure period.  We followed the manufacturer’ s recommendations with 
the following adjustments:  The lysis buffer and water contained 20 mM and 1mM of 
TEMPO (Sigma, St. Louis, MO) reagent (an antioxidant), respectively.  Also, all procedures 
were carried out with the samples on ice.  The AP site assay was then carried out as 
previously described (Nakamura and Swenberg, 1999).         
 
Statistical analysis.  All statistical analyses were performed using the GraphPad Prism 
version 4.0 software package (GraphPad Software Inc., San Diego, CA).  Probability values 
<0.05 were considered significant.  Statistical analysis for all experiments consisted of 
parametric t-tests unless otherwise indicated. 
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Results: 
Thiobarbituric acid reactive substances (TBARS) generated by iAs3+ or DMAs3+.  We 
used the cell-free TBARS assay to detect whether iAs3+ or DMAs3+ would undergo redox-
cycling generating reactive oxygen species.  Neither iAs3+ (1 or 10 µM) or DMAs3+ (1 or 10 
µM) induced an increase in TBARS when compared to KGM alone (Fig. 3-1).  On the 
contrary the metal rich control PM, DOFA (oil fly ash recovered from a boiler in Durham, 
NC), induced about a  3-fold increase in TBARS.    
 
DNA damage induced by H2O2 with 4 h arsenic pretreatment.  The BEAS-2B cells were 
incubated with iAs3+ or DMAs3+ (in KGM) for 4 h at 37oC, rinsed with PBS, and then 
exposed to 20 µM H2O2 (in PBS) for 30 min at 4oC (Fig. 3-2a).  The 4oC incubation is done 
in order to inhibit enzymatic activity (such as DNA repair and antioxidant enzymes).  We 
found that the control cells that were pre-treated with KGM and subsequently exposed to 20 
µM H2O2 had a significant increase in DNA breaks (668 µm2) when compared to the control 
cells that were not exposed to H2O2 (370 µm2, p < 0.05).  The cells that were pre-treated with 
10 µM iAs3+, 1 µM or 10 µM DMAs3+ and subsequently exposed to 20 µM H2O2 had areas 
of 946 µm2, 1167 µm2, and 1237 µm2, respectively, and sustained a significant increase in 
DNA area when compared to H2O2-exposed control cells (i.e., pre-treated with media alone) 
(668 µm2, p < 0.05).   
    When the BEAS-2B cells were exposed to 20 µM H2O2 at 37oC instead of 4oC after pre-
treatments, the control cells had a significant increase in DNA area (708 µm2) when 
compared to the control cells that were not exposed to H2O2 (364 µm2, p < 0.05) (Fig. 3-2b).  
However, the DNA area for the cells that were pre-treated with 10 µM iAs3+ and 1 µM 
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DMAs3+ and subsequently exposed to H2O2 (687 µm2 and 772 µm2) was not significantly 
different to the DNA area of the H2O2-exposed control cells. Pre-treatment with 10 µM 
DMAs3+ and subsequent exposure to H2O2 did sustain a significant increase in DNA area 
(1334 µm2) when compared to H2O2-exposed control cells (p < 0.05). 
 
Abasic sites in cells pre-treated with iAs3+ and DMAs3+.  The BEAS-2B cells were 
exposed to 10 µM iAs3+ or 1 µM DMAs3+ for 4h and subsequently exposed to 20 or 100 µM 
H2O2 for 30 min at 4oC (Fig. 3-3a).  None of the treatment combinations showed were 
significantly different (p > 0.05).  However, the KGM pre-treated control cells sustained 1.0 
AP site/106 nucleotides whereas the H2O2 treated controls sustained 1.8 and 1.9 AP sites/106 
nucleotides at 20 and 100 µM H2O2, respectively.  The cells pre-treated with 10 µM iAs3+ 
that were later exposed to 100 µM H2O2 sustained 2.6 AP sites/106 nucleotides compared to 
the corresponding control cells value (1.9 AP sites/106 nucleotides).    
    When BEAS-2B cells were pretreated with 10 µM iAs3+ or 1 µM DMAs3+ for 4h and 
subsequently to 20 or 100 µM H2O2 for 30 min at 37oC, none of the treatment combinations 
showed were significantly different (p > 0.05) (Fig. 3-3b).  The KGM pre-treated control 
cells sustained 2.1 AP sites/106 nucleotides whereas those control cells subsequently exposed 
to H2O2 sustained 2.2 and 3.0 AP sites/106 nucleotides at 20 and 100 µM H2O2, respectively.  
These baseline values are increased when compared to those found at 4oC.  The number of 
AP sites in the cells pre-treated with 10 µM iAs3+ that were later exposed to 100 µM H2O2 
also sustained a non-significant increase in the number of AP sites when compared to the 
corresponding control cells (3.0 vs. 3.5 AP sites/106 nucleotides).  DMAs3+ pre-treatment had 
no effect on the numbers of H2O2–induced AP sites observed at both temperatures used.  
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Vanadium and iron effects on H2O2-induced DNA damage.  Similar to the previous 
experiments with arsenic pretreatment before H2O2 exposure,  BEAS-2B cells were 
incubated with Fe3+ (FAC) or V4+ (VOSO4) in KGM for 4 h at 37oC, rinsed with PBS, and 
then exposed to 20 µM H2O2 (in PBS) for 30 min at 4oC (Fig. 3-4).  The cells that were pre-
treated with 100 µM Fe3+ and subsequently exposed to 20 µM H2O2 did not sustain any 
statistically significant increase in DNA area (710 µm2) when compared to the control cells 
upon exposure to H2O2 (668 µm2).  However, the cells that were pre-treated with 50 µM V4+ 
for 4 h and subsequently exposed to 20 µM H2O2 sustained a significance increase in DNA 
area (1499 µm2) when compared to the control cells that were subsequently exposed to H2O2 
(p < 0.05). 
 
Effects of  iAs3+, DMAs3+, Fe3+, or V4+ pretreatment on H2O2 and Fe3+ -induced DNA 
damage after a 20 h recovery period.  The BEAS-2B cells were incubated with media 
alone, iAs3+, DMAs3+, Fe3+, or V4+ (in KGM) for 4 h at 37oC, rinsed with PBS, and incubated 
with fresh KGM for 20 h.  It has been shown that V4+ pre-treatment for 24 h downregulates 
DMT1 mRNA and protein levels and activity and leads to increased cellular lipid 
peroxidation (Ghio et al., 2005).  After the 20 h period the cells were incubated with H2O2 
and Fe3+ for 30 min at 4oC (Fig. 3-5) to create a redox-cycling environment.  The cells that 
were pre-treated with vanadium and subsequently exposed to the H2O2 and Fe3+  combination 
sustained a two-fold increase in DNA area (1252 µm2) relative to the control cells (pretreated 
with KGM alone) that were exposed to H2O2 (546µm2; p<0.05).  In the cells pre-incubated 
with iron and later challenged with H2O2 and Fe3+  we observed a decrease, though non-
statistically significant,  in DNA area when comparing against the controls pre-treated with 
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KGM and subsequently challenged with H2O2 (419 µm2 in the Fe3+ pre-treated vs. 546 µm2 
in the controls).  In the cells pre-incubated with iAs3+ and DMAs3+ and subsequently 
challenged with H2O2 and Fe3+  we also did not observe any significant increases in DNA 
area (458 and 528 µm2 respectively) when comparing against the control cells that were 
challenged with H2O2 (546 µm2).  None of the cells pre-treated with the arsenicals or the 
metals and subsequently challenged with PBS alone (i.e., 0 µM H2O2) had any changes in 
DNA area in relation to the control.                
 
SCGE assay of BEAS-2B cells pre-treated with iAs3+ or DMAs3+ for 24 h and 
subsequently exposed to H2O2 + FAC.  The BEAS-2B cells were incubated with iAs3+ or 
DMAs3+ (in KGM) for 24 h at 37oC, and then exposed to 20 µM H2O2 + FAC (in PBS) for 30 
min at 4oC.  We found that the control cells that were pre-treated with KGM and 
subsequently exposed to 20 µM H2O2 + FAC had a significant increase in DNA breaks (645 
µm2) when compared to the control cells that were not exposed to H2O2 + FAC (394 µm2, p 
< 0.05) (Fig. 3-6).  The cells that were pre-treated with 1 µM DMAs3+ and subsequently 
exposed to H2O2 + FAC sustained a significant increase in DNA area (1336 µm2) when 
compared to the control cells that were exposed to 20 µM H2O2 + FAC (645 µm2, p < 0.05).  
None of the other treatment groups sustained any significant differences in DNA area.   
 
Discussion: 
    We provide data that suggest iAs3+, DMAs3+, and V4+ pre-treatment can sensitize a human 
bronchial epithelial cell line to H2O2-induced DNA damage.  We previously demonstrated 
that exposure to non-cytotoxic doses of iAs3+ by itself did not induce DNA damage in the 
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BEAS-2B cell line as assessed by the SCGE assay (Molinelli et al., 2006a).  However, 
DMAs3+ could induce DNA damage directly.   Additionally exposures of the cells to Fe3+ or 
V4+ for 4h have no effect on DNA damage at the concentrations evaluated (Fig 3-4).  It is 
important to stress that the doses of Fe3+ and V4+ used have already been reported to be non-
toxic on our cell line (Samet et al., 1996) which we confirmed visually by trypan blue dye 
exclusion and cell morphology.      
    We found that BEAS-2B pre-treated with iAs3+ (at 10 M) and DMAs3+ (at 1 and 10 M) 
and subsequently exposed to H2O2 at 4oC sustained a statistically significant increase in DNA 
breaks when compared to control cells that were pre-treated with cell media alone (Fig. 3-
2a).  However, only the cells that were exposed to a higher dose of DMAs3+ (10 M) 
sustained an increase in H2O2-induced DNA breaks at 37oC (Fig. 3-2b).  We also found that 
V4+ pre-treatment also sensitized the cells to H2O2-induced DNA damage at 4oC (Fig. 3-4).  
This increase was more pronounced than the one observed with the iAs3+ or DMAs3+ pre-
treated cells.  It is possible that V4+ is undergoing redox-cycling as it has been demonstrated 
that this metal is capable of sustaining such reaction (Valko et al., 2005; Lloyd et al., 1998).  
However, Fe3+ a metal that could also undergo redox-cycling reactions did not sensitize the 
cells to H2O2-induced DNA damage.  It is possible that Fe3+ was transported intracellularly, 
and inactivated by being bound to ferritin. 
    Several factors could account for the organic and inorganic arsenic-induced sensitization 
to H2O2-induced DNA damage.  Some of these could include depletion of antioxidants (e.g. 
GSH), inhibition of DNA repair, stimulation of DNA nicking by damage dependent 
enzymes, or Fenton-like reactions between As and H2O2.  There are no reports in the 
literature suggesting that As could undergo redox-cycling.  Moreover, both As compounds 
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failed to induce an increase in TBARS at the concentrations used in these studies (Fig. 3-1).  
Thus, it is very unlikely that redox-cycling could explain the sensitization to H2O2.  The 
inhibition of DNA repair is a possible mechanism, however there are several caveats.  It has 
been suggested that iAs3+ exposure can inhibit the DNA repair process but it has also been 
shown that it does not inhibit DNA repair enzymes in some cell types (Rossman, 2003).  At 
4oC we observe a stronger sensitization than that at 37oC.  This would suggest that DNA 
repair or antioxidant enzyme activities are involved in the protection against DNA damage 
induced by our treatments.  Thus, under conditions in which any of these enzyme activities 
are inhibited there is the potential for As to act as a co-carcinogen with H2O2.  It is also 
possible that As might stimulate DNA nicking (creating DNA SSBs) by damage dependent 
enzymes.  Although at 4oC enzymatic activity should be diminished, the results from the AP 
site assay (Figs. 3-3a & 3-3b) suggest that iAs3+ might play a small role even though the 
values obtained were not statistically significant (see discussion below).  It is also important 
to mention that DNA damage exhibits a bimodal dose-response curve with H2O2  exposure; 
at low concentrations H2O2 reacts with Fe present at the N7 position of guanine generating 
specific nicks in DNA (i.e., mode I), and at high doses the DNA damage observed is 
consistent with free hydroxyl radical attack (i.e., mode II) (Henle et al., 1999, Rai et al., 
2005).  The concentration of used throughout our studies (20 µM) should likely generate 
mode I damage.            
    As mentioned in the results section and Figures 3-3a and 3-3b the arsenic pre-treatment did 
not seem to induce increases in AP sites when compared to KGM pre-treated cells after both 
groups received H2O2.  Some groups, such as the cells pre-treated with iAs3+ and 
subsequently exposed to 100 µM H2O2 did have increases at both 4 and 37oC.  Several 
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factors might explain these findings.  It could be argued that the shortcoming is 
methodological because the number of samples per group tested was 3 and the differences 
between treatments and controls in this assay are generally small (1-2 AP sites/106 
nucleotides in our results).  Nakamura et al. (2000) reported that millimolar doses of H2O2 
were required to induce significant increases in AP sites in HeLa cells.  However, after a 
more detailed examination it was concluded that H2O2 induced a biphasic dose-response 
curve with AP site increases after 60 µM exposures on HeLa cells (Nakamura et al., 2003b).  
Thus, a more detailed examination of the effects of H2O2 on the BEAS-2B cells line could 
reveal at which dose they are more sensitive.  Still, on our studies a higher number of 
samples might be sufficient to show statistical significance.  As an example the p-value for 
the difference between the KGM treated cells and those exposed to 20 µM H2O2 (Fig. 3-3a, 
first two bars) was 0.0671 (using the two-tailed t-test).  We also observed that the baseline in 
the experiments carried out at 37oC was increased in all treatment groups.  Thus it can be 
argued that the 4oC treatment limits the DNA glycosylase activity of repair enzymes.  We 
also found that at both temperatures used, the 10 µM iAs3+ pre-treated cells that were 
subsequently exposed to 100 µM H2O2 sustained non-significant increases in AP sites when 
compared to the cells pre-treated with KGM (1.9 vs. 2.6 at 4oC & 3.0 vs. 3.5 at 37oC).  Thus, 
it is possible that iAs3+ pre-treatment increases the amount of BER excisable lesions (such as 
8-oxo-dG) and that the 4oC treatment inhibits the activity of the enzyme.  These results 
would be consistent with those of Wang and collaborators (2002) were they demonstrate that 
treatment of comet assay slides with Fpg (an enzyme that excises purine DNA adducts) 
increases the amount of detectable lesions.  Thus, it is possible that an increased number of 
experiments in the AP site assay might improve the statistical analysis on our experiments.  
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Interestingly, DMAs3+ which yielded the most sensitization to H2O2 in the SCGE assay had 
almost no effect under the AP site assay.  It is possible that most of the effect induced by 
DMAs3+ consists of strand breaks (detectable by the comet assay) and not DNA adducts or 
direct AP sites detectable by our aldehyde reactive probe.       
    The membrane protein DMT1 normally transports divalent cations, such as iron, inside the 
cells.  As mentioned in the introduction it has been demonstrated that DMT1 can be 
upregulated by iron and downregulated by vanadium (Wang et al., 2002b; Ghio et al., 2005) 
with resulting cellular oxidative stress levels dependent on DMT1 activity.  The upregulation 
of DMT1 has been suggested to serve as a detoxification mechanism in the airways as it 
removes catalytically active ferrous iron from the epithelial surface (where it can react with 
particles, H2O2, or other compounds) and into the cell where it is bound by ferritin (and is 
oxidized to the ferric state) (Ghio et al., 2005).  On our studies, DMT1 levels and activity 
were upregulated by incubating BEAS-2B cells with Fe3+, and downregulated by V4+ 
incubation.  In a similar experimental design, Ghio et al. (2005) demonstrated that the 
upregulation of DMT1 by iron led to a decrease in cellular lipid peroxides after a challenge 
with residual oil fly ash (ROFA) (a combustion derived PM rich in transition metals 
including iron).  In a similar fashion the downregulation of DMT1 by vanadium led to an 
increase in cellular lipid peroxides after a ROFA challenge. In a similar design as that 
described for Fe3+ and V4+ we also incubated the cells with iAs3+ and DMAs3+ and assessed 
for DNA damage.   
    We demonstrated that the downregulation of DMT1 by vanadium sensitized the cells to 
H2O2-induced DNA damage (Fig. 3-5) based on the SCGE assay data.  We hypothesize that 
the downregulation of DMT1 by vanadium leads to the accumulation of Fe2+ in the 
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extracellular surface as has been suggested by Ghio et al., (2005).  This excess Fe2+ can then 
react with H2O2 generating reactive oxygen species (ROS).  These ROS can then react with 
cell membrane lipids generating lipid hydroperoxides that can induce damage of DNA (Fig. 
3-7).  Alternatively, a similar mechanism as that described in the previous section (redox-
cycling by V4+) could be occurring.  However, given the fact that the cells underwent a 
recovery period of 20 h without the metal this scenario is not very feasible (i.e. during this 
recovery period As pre-treatment failed to sensitize the cells to H2O2-induced DNA damage).      
    In the cells pre-incubated with iron (i.e. where DMT1 activity was upregulated) and later 
challenged with H2O2 + FAC (Fig. 3-5) there was a slight decrease in DNA area when 
comparing against the cells pretreated with media before H2O2 exposure.  However, this 
decrease was not statistically significant, possibly due to the sample number or to the limit to 
how much the DNA area can be decreased from baseline damage. 
    The data suggest that iAs3+ and DMAs3+ exposure does not alter H2O2 + FAC –induced 
DNA damage after a 20 h recovery period (Fig. 3-5).  These results contrast with those 
presented in Figures 3-2a and 3-2b where there was no recovery period and the arsenicals did 
sensitize the cells to H2O2-induced DNA damage.  These results suggest that during the 
recovery period (without the arsenicals present in the media) the cells develop resistance to 
increased DNA damage induced by a subsequent H2O2 exposure.  It can be speculated that 
the cells either export iron, bind it in a less catalytically active state, or upregulate a defense 
mechanism.  The data we have shown (Molinelli et al, 2006) suggests that >50% of DMAs3+ 
or metabolites accumulated in the first 4 h are moved extracellularly which may account for a 
decreased DNA damage after 20 h of recovery.   
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    In order to determine if a longer incubation period with the arsenicals was required to alter 
the expression of DMT1 and alter the sensitization to H2O2-induced DNA damage we 
incubated the BEAS-2B cells with iAs3+ (1 and 10 µM) and DMAs3+ (0.1 and 1 µM) for 24h.  
These doses range from sub-toxic to moderately toxic after 24 h incubations (Molinelli et al., 
2006a).  We found that only the cells exposed to 1 µM DMAs3+ sensitized the cells to H2O2 
and FAC-induced DNA damage when compared to the cells pre-treated with KGM alone and 
subsequently challenged with H2O2 and FAC.  These results are similar to those observed 
after the 4 h incubation (Fig. 3-1).  Thus, it is not possible to ascertain whether DMT1 
regulation is playing a role.  However, in the iAs3+ pre-treated cells subsequently exposed to 
H2O2 and FAC we did not observe the sensitization seen at 4 h (Fig. 3-1).  Thus, the longer 
exposure to iAs3+ induces less DNA damage than the shorter exposure.  The specific 
mechanism accounting for this observation remains to be determined.  However, we could 
speculate that some form of metal transport or antioxidant response could be occurring. 
    In summary we have demonstrated that H2O2-exposed cells that were pre-treated with 
iAs3+ (at 10 M) and DMA3+ (at 1 and 10 M) sustained more DNA damage than control 
cells that were pre-treated with cell media alone.  This provides support to the hypothesis that 
arsenic compounds can act as co-carcinogens with H2O2.  This mechanism could potentially 
occur in the lungs, where H2O2 is present, and could play a role in As-induced lung 
carcinogenesis in certain situations (such as during lung disease).  We also demonstrated that 
DMT1 modulation by V4+ and the subsequent alteration in iron homeostasis sensitizes airway 
epithelial cells to oxidative DNA damage induced by H2O2.  These results provide further 
evidence that increased DMT1 expression serves as a protective mechanism in the lungs by 
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stimulating cells to intracellularly transport and bind iron, thus making it unavailable to 
participate in ROS generation and increased DNA damage (Fig. 3-7). 
    Arsenic induced sensitization to oxidative DNA damage might be an important 
carcinogenic pathway in susceptible individuals (e.g. those with altered metabolic or DNA 
repair pathways or those with chronic pulmonary disease).  Future studies will examine the 
specific mechanisms (e.g., reduced glutathione involvement, arsenic transport mechanisms) 
responsible for the arsenic induced sensitivity to H2O2.   
 79 
Acknowledgements: 
The authors thank Lisa Dailey and Jackie Stonehuerner for technical assistance.  We also 
thank Zuzana Drobna for useful methodological recommendations.  AM supported by 
EPA/UNC CT827206 and NIEHS T32-07126. 
 
 
 
 
 
 
 
 80 
Figure Legends: 
Figure 3-1.  TBARS Assay.  The thiobarbituric acid reactive substances (TBARS) assay is a 
cell-free system used to determine the oxidative potential of an agent.  Arsenite and DMAs3+ 
at 1 and 10 µM were incubated for 2 h with H2O2, deoxyribose and ascorbate at 37oC.  
Thiobarbituric acid is then added to the solution were it reacts with any malondialdehyde (an 
oxidation product) yielding a pink chromogen.  Both arsenicals failed to induce a significant 
increase in TBARS at the doses used (n = 3).    
 
Figure 3-2a.  DNA damage induced by H2O2 at 4oC on iAs+3 or DMAs3+ pre-treated 
cells.  In order to assess whether arsenic pre-exposure affects oxidative DNA damage 
induced by hydrogen peroxide we pre-treated the BEAS-2B cells with 10 µM iAs+3 and 1 
and 10 µM DMAs3+ for 4 h at 37oC.  Subsequently, we rinsed the cells and exposed them to 
20 µM H2O2 for 30 min. at 4oC.  After the exposures we found a statistically significant 
increase (p < 0.05) in comet area between the cells that were pre-treated with iAs3+ and then 
received H2O2 for 30 min, and those that received H2O2 alone for 30 min.  We also found a 
statistically significant increase in comet area between the cells that were pre-treated with 1 
and 10 µM DMAs3+ at 37oC for 30 min. and then received H2O2 for 30 min., and those that 
received H2O2 alone for 30 min. (n = 3 independent experiments with 150-200 observations 
each in all groups examined except for the control ± H2O2 group with n = 9 independent 
experiments).    
 
Figure 3-2b.  DNA damage induced by H2O2 at 37oC on iAs+3 or DMAs3+ pre-treated 
cells.  We repeated the experiment described on figure 3-2a but exposing the cells to H2O2 at 
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37oC.  We used 37oC in order to replicate physiological conditions were DNA repair and 
antioxidant enzymes are active.  At this temperature we found that only the cells that were 
pre-treated with 10 µM DMAs3+ and subsequently exposed to H2O2 had a statistically 
significant (p < 0.05) increase in DNA area.  (n = 2-4 independent experiments with 150-200 
observations each). 
 
Figure 3-3a.  AP sites induced by H2O2 at 4oC on iAs+3 or DMAs3+ pre-treated cells.  In 
order to assess whether arsenic pre-exposure affects AP sites induced by hydrogen peroxide 
we pre-treated the BEAS-2B cells with 10 µM iAs+3 and 1 and 10 µM DMAs3+ for 4 h at 
37oC.  Subsequently, we rinsed the cells and exposed them to 20 µM H2O2 for 30 min. at 
4oC.  No statistically significant increases in AP sites were detected.  (n = 3 independent 
experiments).  
 
Figure 3-3b.  AP sites induced by H2O2 at 37oC on iAs+3 or DMAs3+ pre-treated cells.  In 
order to assess whether arsenic pre-exposure affects AP sites induced by hydrogen peroxide 
we pre-treated the BEAS-2B cells with 10 µM iAs+3 and 1 and 10 µM DMAs3+ for 4 h at 
37oC.  Subsequently, we rinsed the cells and exposed them to H2O2 for 30 min. at 37oC.  No 
statistically significant increases in AP sites were detected.  (n = 3 independent experiments).   
 
Figure 3-4.  DNA damage induced by H2O2 at 4oC on Fe+3 or V4+ pre-treated cells.  
Similar to the previous experiments with arsenic pre-tretment before H2O2 exposure,  BEAS-
2B cells were incubated with Fe3+ or V4+ in KGM for 4 h at 37oC, rinsed with PBS, and then 
exposed to 20 µM H2O2 (in PBS) for 30 min at 4oC.  The cells that were pre-treated with 100 
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µM Fe3+ and subsequently exposed to 20 µM H2O2 did not sustain any statistically 
significant changes in DNA area when compared to the control cells upon exposure to H2O2.  
However, the cells that were pre-treated with 50 µM V4+ for 4 h and subsequently exposed to 
20 µM H2O2 sustained a significance increase in DNA area when compared to the control 
cells that were subsequently exposed to H2O2.  (n = 2-3 independent experiments with 150-
200 observations each in all groups examined except for the control ± H2O2 group with n = 9 
independent experiments).    
 
Figure 3-5.  Effect of Fe3+, V4+, iAs3+ and DMAs3+ on H2O2-induced oxidative DNA 
damage in the presence of iron.  BEAS-2B cells were treated with KGM, iAs+3 (10 µM), 
DMAs3+ (1µM), ferric ammonium citrate (FAC) (100 µM, which increases DMT1), or 
vanadyl sulfate oxide (50 µM, which decreases DMT1) for 4 h.  The cells were then rinsed 
and the medium replaced with KGM.  Twenty hours later the cells were exposed to either 
KGM, 100 µM FAC, or 100 µM FAC + 20 µM H2O2 for 30 min. at 4oC.  (n = 2-4 
independent experiments with 150-200 observations each in all groups examined).       
 
Figure 3-6.  DNA damage induced by H2O2 at 4oC on cells pre-treated for 24 h with 
iAs+3 or DMAs3+.  The BEAS-2B cells were incubated with iAs3+ or DMAs3+ (in KGM) for 
24 h at 37oC, and then exposed to 20 µM H2O2 + FAC (in PBS) for 30 min at 4oC.  We found 
that the control cells that were pre-treated with KGM and subsequently exposed to 20 µM 
H2O2 + FAC had a significant increase in DNA breaks when compared to the control cells 
that were not exposed to H2O2 + FAC.  The cells that were pre-treated with 1 µM DMAs3+ 
and subsequently exposed to H2O2 + FAC sustained a significant increase in DNA area when 
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compared to the control cells that were exposed to 20 µM H2O2 + FAC.  None of the other 
treatment groups sustained any significant differences in DNA area.  (n = 2 independent 
experiments with 150-200 observations each).    
 
Figure 3-7.  Hypothesis for airway epithelial cell DNA damage by vanadium when 
DMT1 is downregulated.  DMT1 expression serves as a protective mechanism in the lungs 
by stimulating cells to intracellularly transport and bind iron, thus making it unavailable to 
participate in ROS generation and increased DNA damage.  If DMT1 is blocked by V4 an 
accumulation of extracellular iron could occur.  This iron can in turn react with H2O2 leading 
to the generation of ROS.  These ROS can damage the cell membrane generating lipid 
hydroperoxides that could potentially increase damage to DNA.   
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Figure 3-2b 
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Figure 3-3a 
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Figure 3-3b 
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Figure 3-4 
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Figure 3-5 
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Figure 3-6 
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Figure 3-7 
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Abstract: 
    Arsenic is a human lung carcinogen whose mode of action is still under debate.  It has also 
been proposed that arsenic can potentiate the effects of other agents, including carcinogens.  
In previous experiments we found that pretreatment of human bronchial epithelial cells with 
inorganic (iAs3+) or organic (DMAs3+) trivalent arsenicals sensitizes the cells to hydrogen 
peroxide (H2O2)-induced DNA damage.  We hypothesized that such sensitization could be 
caused by inhibition of DNA repair, stimulation of DNA nicking by damage dependent 
enzymes, or depletion of antioxidants.  In this paper we address the possible role played by 
antioxidant status, specifically GSH depletion and supplementation.  On our previous studies 
we also found differences in intracellular levels of elemental As after exposure of the cells to 
iAs3+ and DMAs3+.  In this paper we further examine what role might play the transport of 
iAs3+ in the sensitization this compound induces to H2O2.  We found that in iAs3+ treated 
cells where As efflux was inhibited (by blocking the Mrp1 and p-glycoprotein transporters), 
H2O2-induced DNA damage remained unchanged.  We also observed that GSH depletion 
prior to exposure of the BEAS-2B cells with iAs3+ sensitized them to H2O2-induced DNA 
damage, however it is possible that the GSH depleting agent affected the response.  GSH 
supplementation had no effect on the iAs3+-induced sensitization following H2O2 exposure.  
Conversely, GSH depletion sensitized the cells to more DMAs3+-induced DNA damage after 
H2O2 exposure than what DMAs3+ followed by H2O2 in non-GSH depleted cells induced.  
We also determined that the GSH depleting agent was not responsible for this increase.  
Moreover, GSH-EE supplementation depressed the DMAs3+-induced sensitization to the 
point that the response is almost identical to that of GSH-EE supplemented cells pre-treated 
with KGM alone followed by H2O2.  In summary we have found that GSH levels can play an 
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important role in the DMAs3+ sensitization to H2O2-induced DNA damage in lung cells.  This 
finding raises possible concerns about susceptible populations who may be low in lung cell 
GSH content and who also possess high methylation rates of inorganic arsenic. 
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Introduction: 
    Arsenic is perhaps one of the oldest and most studied xenobiotics known to toxicology.  
The adverse health effects of arsenic have been well described but there are still many 
questions unanswered regarding the carcinogenic mode of action (MOA).  Some of the 
hypotheses proposed concerning the MOA have centered on its effects on DNA repair and 
the induction of oxidative stress (NRC, 2001).  Arsenic is also capable of potentiating the 
effects of other agents, including carcinogens.  Some documented examples include 
benzo[a]pyrene in vitro with liver cell cultures (Maier et al., 2002; Lau and Chiu, 2006), UV 
light in a mouse model (Burns et al., 2004), co-mutagenicity with other metals in mammalian 
cells (Hartwig & Schwerdtle, 2002), and docosahexaenoic acid producing reactive oxygen 
species and lipid peroxidation in the HL-60 phagocyte cell line (Sturlan et al., 2003). In 
previous studies from our laboratory we demonstrated that exposure of a lung epithelial cell 
line, the BEAS-2B, to trivalent organic arsenicals induces more cytotoxicity and genotoxicity 
than exposure to inorganic arsenicals (Molinelli et al, 2006a).  We also demonstrated that 
H2O2-exposed cells that were pre-treated with iAs3+ and DMAs3+ (at <10 M) had an 
increase in DNA strand breaks when compared to H2O2-exposed control cells (pre-treated 
vehicle) suggesting that these arsenicals sensitize the cells to oxidant-induced damage.   
    Arsenic is thought to be transported out of the cell via the multidrug resistance-related 
protein 1 (Mrp1), a member of the ATP-binding cassette (ABC) superfamily of proteins, and 
by p-glycoprotein, another ABC superfamily member (Leslie et al., 2001).  It has been 
postulated that As-glutathione complexes are required for the biliary excretion of arsenic by 
the MRP2/cMOAT transporter (Kala et al., 2000).  Human bronchial epithelial cells in 
culture are known to express both Mrp1 and p-glycoprotein (Lehmann et al., 2001).  
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Trivalent arsenic compounds are known to be reactive with protein sulfhydryl groups 
including GSH and cysteine (Scott et al., 1993; Delnomdedieu et al., 1994).  This can lead to 
an impairment of cellular protein function.   
    Given the role that the multi-drug resistance protein 1 (Mrp1) and p-glycoprotein (p-gp) 
play in arsenic transport we determined whether the activity of these proteins are factors to 
consider in the arsenic sensitization to H2O2-induced oxidative DNA damage (Molinelli et 
al., 2006b).  To examine the role of these two transporters in arsenic-induced responses, we 
inhibited the transporter activity in the BEAS-2B cell line with indomethacin (Mrp1 
inhibitor) and verapamil (p-gp inhibitor) concurrent with cell incubation with iAs3+ and 
DMAs3+.  DNA damage was then determined after cell exposure to H2O2.  Our hypothesis is 
that inhibition of iAs3+ or DMAs3+ transport via Mrp1 and p-gp should increase DNA 
damage.   Given the role GSH plays in antioxidant defense and cellular As transport we also 
determined whether GSH depletion or enhancement would play a role in arsenic-induced 
sensitization to H2O2-induced DNA damage.  GSH levels in BEAS-2B cells were decreased 
with buthionine sulfoximine (BSO) and enhanced with GSH ethyl ester (GSH-EE) before 
exposing the cells to iAs3+ or DMAs3+ followed by H2O2.  Our hypothesis is that increased 
levels of cellular GSH will attenuate iAs3+ or DMAs3+ induced sensitization to DNA damage 
in response to H2O2 exposure.   
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Methods: 
Chemicals and cell cultures.  All chemicals used were purchased from Sigma Corp. (St. 
Louis, MO) unless otherwise noted.  14C-doxorubicin-HCl (2.07 GBq/mmol) and 3H-
vincristine sulphate (222 GBq/mmol) were purchased from GE Healthcare/Amersham 
Biosciences (Buckinghamshire, UK).  Sodium arsenite and indomethacin were purchased 
from Sigma (St. Louis, MO).  Verapamil was purchased from Biomol (Plymouth Meeting, 
PA).  Dimethylarsine iodide (DMAs3+) was synthesized by Dr. William R. Cullen 
(University of British Columbia, Vancouver, Canada) using previously described methods 
(Cullen et al., 1984 and Styblo et al., 1997). BEAS-2B cells (S6 subclone; passages 72-95) 
were obtained courtesy of Drs. Curtis Harris and John Lechner from the National Institutes of 
Health (Reddel et al., 1988).  This is an immortalized line of normal human bronchial 
epithelium.  The cell media used was Clonetics (Rockland, ME) keratinocyte growth medium 
(KGM), which is essentially MCDB 153 medium supplemented with 5 ng/ml human 
epidermal growth factor, 5 mg/ml insulin, 0.5 mg/ml hydrocortisone, 4 ml/L bovine pituitary 
extract, and 0.5 ml of GA-1000.  All cells were grown at 37°C and 5% CO2 with fresh media 
being added every other day.  When cells reached 95% confluence they were split, counted, 
and seeded onto tissue culture plates.  Upon reaching 95% confluence the cells were then 
exposed as described below.   
 
Cell exposures.  For all experiments we used freshly prepared solutions of sodium arsenite 
(iAs3+), or DMAs3+.  Working solutions of H2O2 were also prepared fresh from 30% stock 
bottles immediately before it was added to the cells.  Both arsenicals were dissolved in KGM 
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for the exposures.  After the initial exposures the cells were rinsed twice with phosphate 
buffered saline (PBS) (Gibco, Frederick, MD) and exposed to H2O2 in PBS for 30 min.     
 
Mrp1 and p-gp inhibition.  Indomethacin inhibits Mrp1 activity (Matsunaga et al., 2006) 
and verapamil inhibits p-gp activity (Lehmann et al., 2001).  In separate experiments, the 
incubation time, transport inhibitor concentrations, and cell viability were optimized for 
subsequent studies utilizing arsenic exposure.  The BEAS-2B cells were seeded onto 12-well 
cell culture plates and incubated with varying concentrations of the inhibitors for 1 h.  
Subsequently we added the known Mrp1 substrate 14C-doxorubicin-HCl (1 X 105 DPM per 
well dissolved in KGM/ethanol) or the p-gp substrate 3H-vincristine sulphate (1 X 105 DPM 
per well dissolved in KGM/ethanol) (final ethanol concentration was <0.1%).  The levels of 
the substrates in the cell lysates (after incubation in dH2O) was determined by standard liquid 
scintillation counting (Packard Tri-Carb 1500, Packard Instrument Company, Meriden, CT) 
every hour for a period of 4 h.  The trypan blue (Gibco, Frederick, MD) dye exclusion assay 
was used to examine cell viability on cells not treated with the radiolabeled ligands.  Based 
on the results obtained from uptake and cytotoxicity (cells >90% viable after 4 h and no 
significant detachment or other gross morphological changes) we chose combinations of 4 
µg/ml indomethacin together with 10 µg/ml verapamil (Appendix I).  When 10 µM iAs3+ is 
added to the inhibitor combination for 4 h cell viability remains unchanged.  Additional cell 
viability measurements were made by performing the MTT assay as previously described 
(Molinelli et al., 2006a).         
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Alteration of cellular GSH content.  Increased cellular GSH (i.e., supplementation) was 
achieved by incubating the cells with reduced glutathione ethyl ester (GSH-EE).  This 
compound readily enters the cells and is de-esterified yielding GSH (Anderson and Meister, 
1989).  Decreased cellular GSH (i.e., depletion) was achieved by incubating the cells with 
DL-Buthionine-(S,R)-sulfoximine (BSO) for 24 h to inhibit intracellular GSH synthesis 
(Fruehauf et al., 1998). 
 
GSH measurements.  To measure intracellular levels of GSH the BEAS-2B cells were 
seeded onto 6-well plates and incubated with iAs3+, DMAs3+, GSH-EE, or BSO.  Following 
the exposure the cells were rinsed twice with PBS and scraped-off the plate twice with 200 µl 
of 3% perchloric acid (PCA) using a rubber policeman.  The combined scrapings were 
vortexed before storing them at -80oC.  Total GSH was analyzed by means of the DTNB-
GSSG reductase recycling assay for GSH (Anderson, 1985).  The assay was modified for use 
on the Konelab 30 clinical chemistry analyzer (Thermo Clinical Labsystems, Espoo, 
Finland).  
 
Single cell gel electrophoresis (SCGE).  The SCGE assay was performed as previously 
described (Molinelli et al, 2006a).  Briefly, a suspension of cells in 0.6 % low-melting point 
agarose was applied onto a Trevigen Cometslide (Trevigen, Gaithersburg, MD) and allowed 
to solidify at 4oC for at least 15 min.  The slides were then submerged in lysis buffer at 4oC 
for 1 h.  The slides were transferred to an electrophoresis gel box filled with alkaline 
electrophoresis buffer and left submerged for 15 min at room temperature to unwind the 
DNA before electrophoresis for 15 min at 25 volts and 300 mA at room temperature.  Slides 
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were washed twice in neutralization buffer, air dried at room temperature, and stored at 4oC 
in the dark. Ethidium bromide was added to the dried slides to visualize DNA.  DNA 
migration was visualized on a monitor through a camera coupled fluorescent microscope 
(Axiovert 10, Carl Zeiss, Inc., Thornwood, NY) with a fluorescent light source (excitation 
filter of 560 nm and emission filter of 515-590 nm).  An image-analyzing program (Image 1, 
Universal Imaging Co., West Chester, PA) was used to quantify the extent of individual 
DNA damage by measuring the stained DNA migration area.  Approximately 150-200 cells 
per slide were measured from at least 2 independent experiments. 
 
Cellular accumulation of arsenic.  BEAS-2B cells grown on T-25 flasks (90-95% 
confluent) were incubated with 4 µg/ml indomethacin together with 10 µg/ml verapamil for 1 
h at 37oC.  After 1 h, we added iAs3+ to a final concentration of 10 µM while keeping the 
inhibitor concentrations constant, and incubated the cells an additional 4 h.  After the 
exposure the cell media was collected and centrifuged to remove any suspended solids.  The 
cells were then washed twice with PBS and incubated with 2 ml of ultrapure distilled water 
(Milli-Q Gradient, Millipore Corporation, Bedford, MA) at 4oC for 1 h.  Distilled water and 
cells were then transferred to washed and tared digestion tubes.  The cell lysates (in distilled 
water) were then digested with 1% tetramethylammonium hydroxide, followed with 
concentrated HNO3 (Optima grade, Fisher Scientific, Pittsburgh, PA) and additional distilled 
water to a volume of 6.8 ml.  The digests were incubated for 1 h at 100oC.  KGM media 
samples were equilibrated to room temperature in a clean bench less than 4 hours prior to 
inductively coupled plasma-optical emission spectroscopy (ICP-OES) analysis.  Immediately 
prior to analysis, all samples were diluted volumetrically with 0.75% HNO3.  A PerkinElmer 
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4300DV ICP-OES was used.  The analytical wavelengths used were 188.979 and 193.696 
nm.  The study detection limit was 28 ng As per sample.  All procedures were based on EPA 
Method 200.7 (U.S. EPA, 1991).            
 
Statistical analysis.  All statistical analyses were performed using the GraphPad Prism 
version 4.0 software package (GraphPad Software Inc., San Diego, CA).  Probability values 
< 0.05 were considered significant.  Statistical analysis for all experiments consisted of 
parametric t-tests unless otherwise indicated. 
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Results: 
Effect of iAs3+ efflux inhibition on H2O2-induced DNA damage after iAs3+ exposure.  
The BEAS-2B cells (~95% confluent) were pretreated with both indomethacin and verapamil 
for 1 h, and then iAs3+ (final concentration 10 µM) was added.  The cells were incubated for 
an additional 4 h at 37oC and DNA damage assessed.  Subsequently some cells were further 
exposed to 20 µM H2O2 at 4oC before assessing DNA damage (Fig. 4-1).  There were no 
differences in DNA damage among cells due to pretreatments.  There was a statistically 
significant increase in DNA area (p < 0.05) between the KGM pretreated (control) cells (417 
µm2) and control cells exposed to H2O2 (710 µm2).  Cells that had been pretreated with the 
transport inhibitors sustained a statistically significant increase (p < 0.05) of DNA damage in 
response to H2O2 exposure (1043 µm2) relative to the response of H2O2 exposed vehicle-
pretreated cells.  There was a statistically significant increase in DNA damage in cells 
exposed to iAs3+ and then H2O2 (779 µm2) compared to those that were pre-treated with the 
inhibitors and exposed  in a similar manner (1171 µm2).  
Cellular arsenic content with efflux transporter inhibition.  The arsenic content of the 
BEAS-2B cells pretreated with agents that inhibit MRP1 and p-gp activity was determined to 
examine the extent of the As increase.  BEAS-2B cells were pretreated with indomethacin 
and verapamil (1 h) and then exposed to 10 µM iAs3+ for another 4 h.  The amount of cell-
associated arsenic (not speciated) and in the media was measured by ICP-OES analysis.  
After 4 h the BEAS-2B cells take up roughly 0.6% (i.e., ~38 ng cell associated) of the iAs3+ 
when exposed at 10 µM (Table 4-1).  This As concentration in the cells is about 12.6 ng/mg 
dry weight. When the As efflux transporter inhibitors were present the amount of cell-
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associated As increased to ~0.9% (i.e., ~63 ng cell associated) of the total iAs3+ 
concentration to which the cells were exposed.   
Modulation of cellular GSH levels and arsenic-induced DNA damage.  The BEAS-2B 
were seeded onto 6-well plates and exposed to 1 and 10 µM iAs3+ or DMAs3+ for 4h.  The 
cells were also exposed to GSH-EE (30 min) and BSO (24 h).  Only 10 µM DMAs3+ 
exposure caused a significant (p < 0.05) decrease in GSH (Fig. 4-2).  The 1 µM concentration 
of DMAs3+ caused a ~40% decrease in GSH, but this value was not statistically significant.   
50 µM BSO exposure decreased GSH concentrations by ~95%, while 40 mM GSH-EE 
increased cellular levels by ~65%. 
    Having demonstrated that cellular GSH levels could be modulated by BSO and GSH-EE 
incubation, and that DMAs3+ exposure decreased GSH content, the effect of altered cellular 
GSH content on arsenic-induced sensitization to H2O2-induced DNA damage was assessed.  
BEAS-2B cells were pre-treated at 37oC with BSO for 24 h, and then iAs3+ (final 
concentration 10 µM) or DMAs3+ (final concentration 1 µM) added with BSO present, and 
cells incubated for 4 additional h.  Some cell cultures were then rinsed with PBS before 
exposure to 20 µM H2O2 (4oC) and DNA damage assessed (Fig. 4-3).  Pretreatment of cells 
with BSO or iAs3+ (alone or in combination) did not induce increased DNA damage (Fig. 4-
3a). When cells were exposed to H2O2 following the pretreatment period, BSO pretreatment 
alone (i.e., no arsenic exposure) did not induce a significant increase in DNA damage (902 
µm2) relative to cells pretreated with KGM and exposed to H2O2 (710 µm2).  Cells that had 
GSH depleted via BSO pretreatment and were then subsequently incubated with iAs3+ 
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sustained a significant H2O2–induced increase in DNA area (1169 µm2) relative to cells 
incubated with iAs3+ (779 µm2; p < 0.05).   
    With regards to BEAS-2B cell responses upon GSH depletion and DMAs3+ incubation, 
there were no differences among groups (control values and various treatments) not exposed 
to 20 µM H2O2 (Fig. 4-3b).   With cells exposed to H2O2, in GSH depleted cells DMAs3+ pre-
treatment sensitized the cells to H2O2 (1409 µm2) more than  cells not exposed to BSO and 
then incubated with DMA3+ (1287 µm2) (p < 0.05).  BSO treatment alone (i.e., no further 
DMA3+ incubation) did not induce a greater DNA damage than control cultures (no BSO).  
As noted in previous studies (Molinelli et al, 2006b), DMAs3+ pre-treatment for 4 h sensitizes 
the BEAS-2B cells to H2O2-induced DNA damage (1287 µm2) when compared to the cells 
pre-treated with KGM alone and subsequently exposed to H2O2 (710 µm2; p < 0.05). 
    Cell viability using the MTT assay was determined for cells undergoing GSH depletion 
and arsenic exposures.  BSO pre-treatment (for 24 h) followed by iAs3+ (10 µM) for a further 
4 h did not reduce cell viability when compared to control cells (all groups remained around 
100% of control; range 100-110%).  Additionally, BSO pre-treatment (for 24 h) followed by 
DMAs3+ (1 µM) for a further 4 h did not reduce cell viability when compared to control cells 
(all groups remained approximately 100% of control; range 100-110%).   
 
Effect of GSH supplementation on H2O2-induced DNA damage after arsenic exposure.  
The BEAS-2B cells were pre-treated at 37oC with KGM with or without 40 mM GSH-EE for 
30 min prior to the experiment.  After this pretreatment period with GSH-EE iAs3+ (10 µM) 
or DMA3+ (1 µM) was added while maintaining the GSH-EE concentration constant, and 
cells incubated for another 4 h.  Subsequently cells were exposed to 20 µM H2O2 at 4oC for 
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30 min and DNA damage was assessed.  GSH-EE pretreatment by itself caused a significant 
(p < 0.05) increase in DNA area in the KGM exposed cells that were subsequently exposed 
to H2O2 (950 µm2) when compared to both the non-GSH supplemented cells that were pre-
incubated with KGM and then exposed to H2O2 (710 µm2) and those pre-incubated with 
iAs3+ and then exposed to H2O2 (779 µm2) (Fig. 4-4a).  None of the other groups (non-H2O2 
exposed cells) sustained any significant changes in DNA.  With DMAs3+ incubations, 
DMAs3+ pretreatment significantly (p < 0.05) sensitizes the cells to H2O2-induced DNA 
damage (1287 µm2) when compared to the KGM pretreated cells exposed to H2O2 (710 µm2) 
(Fig. 4-4b).  GSH-EE supplementation significantly (p < 0.05) decreased the DNA damage 
induced by DMAs3+ followed by H2O2 (945 µm2).          
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Discussion: 
    In previous experiments we found that iAs3+ and DMAs3+ sensitized BEAS-2B cells to 
H2O2-induced DNA damage.  We hypothesized that such sensitization could be caused by 
caused by inhibition of DNA repair, stimulation of DNA nicking by damage dependent 
enzymes, or depletion of antioxidants (Molinelli et al., 2006b).  In this paper we address the 
possible role played by antioxidant status, specifically GSH depletion and supplementation, 
as well as intracellular As accumulation.  On our previous studies we also found differences 
in intracellular levels of elemental As after exposure of the cells to iAs3+ and DMAs3+ 
(Molinelli et al., 2006a).  In this paper we further examine what role might play the transport 
of iAs3+ in the sensitization this compound induces to H2O2. 
    We found that in iAs3+ treated cells where As efflux had been at least partially inhibited 
via treatment with pharmacological agents, H2O2-induced DNA damage was statistically 
unchanged (Fig. 4-1).  It is possible that the inhibitor combination alone is responsible for at 
least part of the observed results as the baseline levels of H2O2-induced DNA damage are 
increased in the inhibitor treated cells when compared to the controls (no inhibitor).  
Although it appears that in cells pre-treated with the inhibitors iAs3+ induces more damage 
than the inhibitors alone (1043 vs. 1171 µm2), this difference is not statistically significant (p 
= 0.1447).  Throughout our experiments we did not observe a significant iAs3+-induced 
sensitization of the cells to H2O2 as we previously reported (Molinelli et al., 2006b), though 
there was trend showing more DNA damage in the iAs-treated cells.  This incongruence is 
probably due to the low sample number used in these experiments (n = 2 independent assays) 
when compared to the previous report (n > 4 independent assays).  Because efflux inhibitor 
treatment by itself caused an increase in H2O2-induced DNA damage it is possible that non-
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specific changes in the cells (i.e. altered arachidonic acid metabolism by indomethacin or 
effects on Ca2+ channels by verapamil) could contribute to the sensitization. 
    We observed that GSH depletion (Fig. 4-3a) prior to exposure of the BEAS-2B cells with 
iAs3+ sensitized them to H2O2-induced DNA damage (DNA area = 1169 µm2) when 
compared against the iAs3+ exposed cells that were not GSH depleted and subsequently 
received H2O2 (779 µm2).  Although the difference between the GSH depleted cells exposed 
to KGM alone followed by H2O2 (902 µm2) and the GSH depleted cells exposed to iAs3+ and 
H2O2 (1169 µm2) is non-significant (suggesting that BSO could be partly responsible for the 
sensitization), the difference between the two groups is still large and the non-significance 
could be due to the small sample number.  Thus it is possible that GSH depletion affects the 
iAs3+-induced sensitization to H2O2.  GSH depletion sensitized the cells to more DMAs3+-
induced DNA damage after H2O2 exposure (1409 µm2) than what DMAs3+ followed by H2O2 
in non-GSH depleted cells does (1287 µm2).  Moreover, BSO is not responsible for this 
increase.  Thus, GSH seems to be an important factor in the sensitization of BEAS-2B cells 
to DMAs3+-induced DNA damage following H2O2 exposure.    
    When we supplemented the BEAS-2B cells with GSH-EE (in order to increase the 
intracellular GSH) and subsequently exposed the cells to iAs3+ (Fig. 4-4a) we found that 
supplementation had no effect on iAs3+-induced sensitization to H2O2 (895 µm2) when 
compared to the KGM pre-treated cells that were subsequently exposed to H2O2 (950 µm2).  
Although this value is not statistically significant (p = 0.0762), this finding is still important 
as GSH-EE supplementation completely prevented the iAs3+ sensitization to H2O2-induced 
DNA damage seen on our previous report (Molinelli et al., 2006b).  Thus, we again observe 
that GSH might play a small role on iAs3+-induced sensitization of the BEAS-2B cells to 
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H2O2.  As already mentioned we confirmed that DMAs3+ pre-treatment sensitizes the BEAS-
2B cells to H2O2-induced DNA damage.  However, GSH-EE supplementation depressed this 
DMAs3+-induced sensitization to the point that the response is almost identical as to that of 
GSH-EE supplemented cells pre-treated with KGM alone followed by H2O2 (945 vs. 950 
µm2).  These results provide further evidence for a role for GSH in DMAs3+-induced 
sensitization to DNA damage caused by H2O2.  Paradoxically GSH-EE pretreatment seems to 
increase the baseline damage induced by H2O2. GSH-EE incubation did not increase the 
DNA damage without  H2O2 exposure.   Hollins et al. (2006) observed GSH-EE to be 
effective in decreasing human lymphocyte mitochondrial DNA damage upon exposure to 
tert-butyl-hydroperoxide.   
    Our results make us postulate that DMAs3+ is a more potent sensitizer than iAs3+ to DNA 
damage induced by H2O2.  These results are underscored by the finding that only DMAs3+ 
depleted GSH (Fig. 4-2).  It is interesting to note that it takes one mole of DMAs3+ to 
complex one mole of GSH; but one mole of iAs3+ can complex three moles of GSH (Styblo, 
et al., 1995).  This fact contrasts to our finding that DMAs3+ was more efficient at depleting 
GSH than iAs3+.  A possible explanation for this finding is that more DMAs3+ was present 
inside the cells (was transported in) than iAs3+ thus more of it reacted with GSH.   
    Hirata and collaborators (1988 and 1990) found that depleting GSH in hamsters with BSO 
prior to arsenite administration leads to kidney toxicity (as evidenced by histopathological 
changes) and that inorganic arsenic (not the methylated metabolites) are excreted.  The 
authors conclude that GSH can protect the kidneys from arsenite-induced damage.  On our in 
vitro experiments we found that GSH can protect the cells against DMAs3+-induced 
sensitization to oxidative damage.     
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    It is important to note that pentavalent arsenicals can be reduced by GSH to their trivalent 
forms (Scott et al., 1993; Delnomdedieu et al., 1994).  This reaction would lead to the 
generation of oxidized glutathione (GSSG).  Because arsenite is also known to inhibit GSH-
reductase the intracellular conditions can become oxidative (Styblo and Thomas, 1995).  
Thus, the possible role for iAs3+ in sensitizing cells to H2O2-induced DNA damage cannot be 
discounted as our results are limited due to methodological issues.   
    It has been shown that the levels of GSH and GSSG play an important role in the 
inflammatory response of lung cells and that the levels of GSH can be modulated by multiple 
agents (Rahman et al., 2006).  Moreover, polymorphisms in human arsenic methyltransferase 
(formerly cyt19, now AS3MT) have been identified and it is hypothesized that their variation 
could alter arsenic metabolism (Wood et al., 2006).  It has also been found that children 
might have different levels of cyt19 (AS3MT) than adults (Meza et al., 2005).  In summary 
we have found that GSH depletion can play an important role in the DMAs3+ sensitization to 
H2O2-induced DNA damage and elimination from lung cells.  This finding raises possible 
concerns about susceptible populations who may be low in lung cell GSH content and who 
also possess altered rates of inorganic arsenic.   
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Figure Legends: 
Figure 4-1.  Effect of iAs3+ efflux inhibition on H2O2-induced DNA damage after iAs3+ 
exposure.  INH = combination of 4 µg/ml indomethacin and 10 µg/ml verapamil.  iAs3+ 
concentration was 10 µM and H2O2 concentration 20 µM.  There were no differences in 
DNA damage among cells due to pretreatments.  There was a statistically significant increase 
in DNA area (p < 0.05) between the KGM pretreated (control) cells (417 µm2) and control 
cells exposed to H2O2 (710 µm2).  Cells that had been pretreated with the transport inhibitors 
sustained a statistically significant increase (p < 0.05) of DNA damage in response to H2O2 
exposure (1043 µm2) relative to the response of H2O2 exposed vehicle-pretreated cells.  
There was a statistically significant increase in DNA damage in cells exposed to iAs3+ and 
then H2O2 (779 µm2) compared to those that were pre-treated with the inhibitors and exposed  
in a similar manner (1171 µm2).  (n = 2 independent experiments with 150-200 observations 
each).   
 
Figure 4-2.  Cellular GSH levels.  Only the 10 µM DMAs3+ exposure caused a significant 
(p < 0.05) decrease in GSH.  The 1 µM dose of DMAs3+ caused a ~40% decrease in GSH, 
but this value was not statistically significant.  50 µM BSO exposure decreased GSH 
concentrations by ~95%, while 40 mM GSH-EE increased cellular levels by ~65%.  (n = 2-3 
independent experiments).   
 
Figure 4-3.  Effect of GSH depletion on H2O2-induced DNA damage after arsenical 
compound exposure.  iAs3+ concentration was 10 µM, DMAs3+ concentration was 1 µM, 
and H2O2 concentration 20 µM.  (A) The cells preincubated with BSO and subsequently 
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exposed to 10 µM iAs3+ followed by H2O2 sustained a significant increase (p < 0.05) in DNA 
area (1169 µm2) when compared to the cells that were pre-treated with KGM alone and 
subsequently exposed to iAs3+ followed by H2O2 (779 µm2).  None of the other groups 
sustained significant increases in DNA damage.  (B) The cells pre-incubated with BSO and 
subsequently exposed to 1 µM DMAs3+ followed by H2O2 sustained a significant increase (p 
< 0.05) in DNA area (1409 µm2) when compared to the cells that were pre-treated with KGM 
alone and subsequently exposed to iAs3+ followed by H2O2 (1287 µm2).  DMAs3+ pre-
treatment for 4 h sensitizes the BEAS-2B cells to H2O2-induced DNA damage (1287 µm2) 
when compared to the cells pre-treated with KGM alone and subsequently exposed to H2O2 
(710 µm2).  In GSH depleted cells we also observe that DMAs3+ pre-treatment sensitizes the 
cells to H2O2 (1409 µm2) when compared to KGM pre-treated cells subsequently exposed to 
H2O2 (902 µm2) (p < 0.05).  (n = 2 independent experiments with 150-200 observations 
each).   
 
Figure 4-4.  Effect of GSH supplementation on H2O2-induced DNA damage after 
arsenical compound exposure.  iAs3+ concentration was 10 µM, DMAs3+ concentration was 
1 µM, and H2O2 concentration 20 µM.  (A) GSH-EE pre-treatment by itself caused a 
significant (p < 0.05) increase in DNA area in the KGM exposed cells that were subsequently 
exposed to H2O2 (950 µm2) when compared to both the non-GSH supplemented cells that 
were pre-incubated with KGM and then exposed to H2O2 (710 µm2) and those pre-incubated 
with iAs3+ and then exposed to H2O2 (779 µm2).  None of the other groups sustained any 
significant changes in DNA damage.  (B) DMAs3+ pre-treatment significantly (p < 0.05) 
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sensitizes the cells to H2O2-induced DNA damage (1287 µm2) when compared to the KGM 
pre-treated cells exposed to H2O2 (710 µm2).  GSH-EE supplementation significantly (p < 
0.05) decreased the DNA damage induced by DMAs3+ followed by H2O2 (945 µm2).  (n = 2 
independent experiments with 150-200 observations each).  
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Figure 4-1 
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Figure 4-2 
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Figure 4-3a 
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Figure 4-3b 
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Figure 4-4a 
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Figure 4-4b 
 
 
CHAPTER 5 
 
CONCLUSIONS 
 
    The main objective of this project was to examine in what manner arsenic and H2O2 (an 
oxidant released by inflammatory cells) together damage lung cell DNA.  This interaction 
may provide important information on the carcinogenic mode of action of arsenic.  To 
accomplish this goal we established three specific objectives: 
 
1. To compare the cytotoxicity and DNA damage induced by exposure to organic and 
inorganic arsenicals in human bronchial epithelial cells.   
 
2. To determine whether exposure to arsenic compounds, iron, and vanadium can 
modulate DNA damage induced by H2O2.   
 
3. To determine the role of arsenic transport and antioxidant proteins on arsenic 
sensitization of human bronchial epithelial cells to H2O2-induced DNA damage. 
 
    This section will contain a brief summary of the findings for each specific objective and a 
discussion on how they relate to the main objective of this project and to the ultimate goal of 
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determining whether this information provides an important contribution to the current 
knowledge of arsenic carcinogenesis.   
    For the first objective we sought to evaluate the cytotoxicity and DNA damage induced by 
inorganic and organic arsenic compounds in a human bronchial epithelial cell line.  The data 
collected suggest that DMAs3+ exposure was more cytotoxic than iAs3+ exposure in all the 
cytotoxicity assays used.  It was also found that exposure to 1 µM iAs3+ and 1 – 10 µM 
DMAs3+ did induce significant increases in DNA damage.  However, the increase induced by 
iAs3+ was relatively small, lacked a dose-response relationship, and was not replicated in 
subsequent experiments.  The lack of DNA single strand break damage induced by iAs3+ in 
our system requires further analysis of the mechanism of iAs3+-induced lung cancer.  In order 
to clarify this issue, different techniques examining DNA damage or a different exposure 
system may need to be utilized.  It is also important to mention that we did not find evidence 
of poly(ADP-ribose) polymerase inhibition at the time-points and concentrations tested.  In 
summary we found that DMAs3+ can induce DNA damage by itself whereas iAs3+ does not. 
    These results provide support to the hypothesis that trivalent organic arsenicals are more 
cytotoxic, genotoxic, and pro-inflammatory (i.e. IL-8 induction) than inorganic arsenicals.  
These findings are important as it has been shown that DMAs3+ accumulates in the lungs of 
animal models and given that dimethylarsine, a reduction metabolite of DMAs5+, can react 
with molecular oxygen yielding arsenic radicals (Yamanaka and Okada, 1994; Yamanaka et 
al., 2004).  More importantly, DMAs3+ can produce dimethylarsine gas in some experimental 
systems which can induce ROS (Kitchin, 2001, Yamanaka et al., 2004).  Because 
dimethylarsine gas is excreted via the lungs, and in the lungs we already have high partial 
pressures of molecular oxygen, this pathway could play an important role in arsenic-induced 
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lung carcinogenesis (Kitchin and Ahmad, 2003; Yamanaka et al., 2004; Tapio and Grosche, 
2006). 
    For the second specific objective we sought to evaluate whether exposure to arsenic 
compounds, iron, and vanadium can modulate DNA damage induced by H2O2 (which is a 
potent endogenous oxidant).  H2O2 is produced constitutively by most lung cells, and its 
formation is increased by inflammatory cells such as macrophages and neutrophils after 
exposure to airborne particulate matter and other stimulants (Ward et al., 1986).  Although 
hydrogen peroxide is not considered a human carcinogen by IARC (International Agency for 
the Research on Cancer), there is limited evidence for its carcinogenicity in animals (IARC, 
1999).  Moreover, H2O2 exposure exhibits a bimodal dose-response curve for DNA damage 
whereas at low doses H2O2 reacts with Fe present at the N7 position of guanine generating 
specific nicks in DNA and at high doses the DNA damage observed is consistent with free 
hydroxyl radical attack (Henle et al., 1999, Rai et al., 2005).  H2O2 has also been considered 
to induce cell proliferation via alterations in “messenger” levels (Burdon, 1995).       
    As mentioned in the introduction (section 1.6) it appears that arsenic is capable of 
potentiating the effects of numerous carcinogens.  Moreover, it has been suggested that the 
activity of the divalent metal transporter-1 (DMT1), which participates in the metabolism of 
iron to decrease cellular oxidative stress, can be modulated by exposure to metals (Ghio et 
al., 2005).  
    In summary it was found that H2O2-exposed cells that were pre-treated with iAs3+ (at 10 
M) and DMA3+ (at 1 and 10 M) sustained more DNA damage than control cells that were 
pre-treated with cell media alone.  This provides support to the hypothesis that arsenic 
compounds can potentiate H2O2-induced DNA damage.  This mode of action could 
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potentially occur in the lungs and could play a role in As-induced lung carcinogenesis in 
certain situations (such as during lung disease).  Bower and collaborators (2006) observed 
that exposure of the BEAS-2B cells to 25 µM iAs3+ (as AsCl3) activates the gadd45α gene 
(growth arrest and DNA damage protein 45).  The authors suggest that this activation results 
from the reaction of iAs3+ with H2O2 generating the hydroxyl radical.  The authors also 
suggest that this interaction could generate DNA damage and lipid peroxidation.  Although 
on our experiments we did not observe TBARS after iAs3+ exposure (arguing against As-
H2O2 interactions), the sensitization of the cells to H2O2-induced DNA damage is consistent 
with the findings by Bower et al. (2006).     
    We also demonstrated that DMT1 modulation by V4+ exposure and the subsequent 
alteration in iron homeostasis (shown to increase lipid peroxidation (Ghio et al., 2005)) 
sensitizes airway epithelial cells to oxidative DNA damage induced by H2O2.  These results 
provide further evidence that increased DMT1 expression serves as a protective mechanism 
in the lungs by stimulating cells to intracellularly transport and bind iron, thus making it 
unavailable to participate in ROS generation and increased DNA damage.  However, we did 
not find evidence suggesting that arsenic compounds could act in a similar fashion as V4+.  
Using the same experimental design as with V4+ we exposed the BEAS-2B cells with Fe3+ in 
order to increase the expression of DMT1 (shown to reduce lipid peroxidation, Ghio et al., 
2005).  After the exposure the cells were challenged with Fe3+ and H2O2 and a slight non-
significant decrease in DNA damage was observed (in comparison to Fe3+/H2O2 alone).  
    We also used the cell-free TBARS assay to detect whether iAs3+ or DMAs3+ would 
undergo redox-cycling thus generating reactive oxygen species. Neither iAs3+ (1 or 10 µM) 
nor DMAs3+ (1 or 10 µM) induced an increase in TBARS when compared to KGM alone. 
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This contrasts with the findings of others suggesting that iAs3+ can generate ROS.  For 
example Liu et al., (2001) detected the presence of ROS (by using 2,7-dichlorofluorescein 
oxidation) after exposure of the human-mouse hybrid AL cells to iAs3+.  Liu et al., (2001) 
also found increased ESR signals in liver tissue of mice exposed to iAs3+.  More studies have 
been published regarding ROS generation by arsenicals in both in vitro and in vivo systems 
as discussed in Kitchin and Ahmad, (2003).  The data suggests that neither the inorganic and 
organic arsenicals can support redox-cycling in our system at the concentrations used.  This 
would not be unusual as there are no reports in the literature suggesting that arsenic can 
support such reaction.  However, our results must be interpreted carefully as a possible 
explanation to the negative results we observed is the low doses of arsenic we used with this 
assay.     
    As a result of our finding that iAs3+ and DMAs3+ appear to sensitize the human bronchial 
epithelial cells to H2O2-induced DNA damage we sought to identify some of the factors that 
might be involved in such sensitization.  As discussed in chapter 3 some possible causes for 
this sensitization include effects of arsenic on DNA repair, the oxidant status of the cell, or 
arsenic transport.  In the third specific objective of this project we sought to focus on the role 
of arsenic transport and antioxidant proteins on the arsenic sensitization to H2O2-induced 
DNA damage.   
    In chapter 2 we discussed how DMAs3+ could accumulate in the BEAS-2B cells much 
more efficiently than iAs3+.  Moreover, it is thought that the multidrug transporters Mrp1 and 
p-gp can transport As compounds out of the cell.  Currently no transporters for organic 
arsenicals have been conclusively identified.  For the first part of our experiments we 
inhibited the As efflux transporters Mrp1 and p-gp and subsequently exposed the cells to 
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iAs3+ and followed that exposure with H2O2.  We found that iAs3+ treatment, when As efflux 
has been inhibited, sensitizes the cells to H2O2-induced DNA damage.  However, it is 
possible that the inhibitor combination alone is responsible for at least part of the increase.  
Although it appears that in cells pre-treated with the inhibitors iAs3+ induces more damage 
than the inhibitors alone, this difference is not statistically significant.  We also found that 
adding the inhibitors to the cells almost doubles the amount of iAs3+ they accumulate.  
    It is known that trivalent arsenic compounds can react with protein sulfhydryl groups 
including GSH and cysteine (Scott et al., 1993; Delnomdedieu et al., 1994).  Moreover, 
arsenite is known to inhibit GSH-reductase (in an in vitro cell-free system) potentially 
creating an oxidative state in the cell as less GSSG is reduced to GSH (Styblo and Thomas, 
1995).  Recently it has also been suggested that an arsenic tri-glutathione conjugate is 
required for the efflux of arsenic by Mrp1 (Leslie et al., 2004).  Given the prominent role 
GSH plays in antioxidant defense and cellular transport we sought to determine whether 
GSH depletion would be a factor to consider in arsenic sensitization to H2O2-induced 
oxidative DNA damage.   
    We found that GSH depletion (with BSO incubation) sensitized the cells to more DMAs3+-
induced DNA damage after H2O2 exposure than what DMAs3+ followed by H2O2 in non-
GSH depleted cells does.  Moreover, BSO was not responsible for this increase.  GSH 
depletion had no significant effect on iAs3+ sensitization to H2O2-induced DNA damage.  
Thus, GSH seems to be an important factor in the sensitization of BEAS-2B cells to 
DMAs3+-induced DNA damage following H2O2 exposure.  Furthermore, GSH 
supplementation depressed this DMAs3+-induced sensitization essentially to baseline control 
value (GSH-EE/H2O2 incubation alone).   
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    The data make us postulate that DMAs3+ is a more potent sensitizer than iAs3+ to DNA 
damage induced by H2O2.  These results are underscored by the finding that only DMAs3+ 
depleted GSH levels in the cells whereas iAs3+ did not.  It is interesting to note that it takes 
one mole of DMAs3+ to complex one mole of GSH; but one mole of iAs3+ can complex three 
moles of GSH (Styblo, et al., 1995).  This fact contrasts to our finding that DMAs3+ was 
more efficient at depleting GSH than iAs3+.  A possible explanation for this finding is that 
more DMAs3+ was present inside the cells (was transported in) than iAs3+, thus more of it 
reacted with GSH.  Taken together our results from specific objective 3 provide evidence that 
the interaction between GSH and DMAs3+ can be an important factor in the sensitization this 
organic arsenical causes to H2O2-treated cells.   
    Reactive oxygen species are a consequence of the use of oxygen by living creatures.  Thus, 
they will always be present during normal physiological processes.  Living organisms have 
protective mechanisms against ROS including numerous enzymes such as catalase, 
superoxide dismutase, and glutathione peroxidase (Klaunig and Kamendulis, 2004).  Two of 
the main mechanisms that might be responsible for As-induced genotoxicity are the 
generation of reactive oxygen species and impairment of DNA repair (IPCS, 2001, section 
7.1.6.5).  There are probably hundreds of compounds that act via similar mechanisms and 
ROS have been implicated in a myriad of human diseases including cancer (Klaunig and 
Kamendulis, 2004) and most lung diseases (Rahman et al., 2006).  As discussed in chapter 1 
(section 1.3) cancer arises from the accumulation of mutations in genes of somatic cells that 
generally regulate cell multiplication.  Sustained DNA damage can lead to the generation of 
mutations.  If the DNA lesions were not correctly repaired and became persistent, the end 
result could potentially lead to cancer.   
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    However, some carcinogens can be non-genotoxic.  Their main mode of action is either by 
promoting cell proliferation or inhibiting apoptosis.  The hallmark of non-genotoxic agents is 
the stimulation of cell proliferation either by acting as xenobiotic mitogens (stimulating 
mitosis), stimulating the release of endogenous mitogens (e.g. growth factors), or by causing 
cytotoxicity (Gregus and Klaassen, 2001).  Non-genotoxic agents can cause cancer by 
increasing the probability that a cell will suffer a spontaneous DNA mutation by the 
increased number of replications.  This probability is especially high on initiated cells that 
have been exposed previously to DNA damaging agents.  It is also worth mentioning that 
wherever there is cell injury there will be an inflammatory response, thus there will also be 
reactive oxygen species produced by inflammatory cells that can aggravate the situation 
(Gregus and Klaassen, 2001). 
    Arsenic is one of the few compounds declared by IARC to have sufficient evidence as a 
human carcinogen, but not as an animal carcinogen.  This could have been a result of 
experimental flaws in study designs and the use of extremely high doses on rodent 
intratracheal administration experiments or other factors (Rosmann, 2003).  Moreover, 
because arsenite does not induce mutations in certain bacterial and mammalian cells, it was 
considered a promoter.  Recent evidence however demonstrates that arsenite does not act as a 
promoter in skin carcinogenesis.  On the other hand arsenate does act as a promoter in 
bladder carcinogenesis (Rossman, 2003).  Thus the species of arsenic and the target organ 
play an important role on its carcinogenesis.  This is highlighted by Cohen et al. (2006) in a 
comparison of animal and human induced carcinogenesis by arsenic.  The authors suggest 
that trivalent metabolites of arsenic formed via the redox and methylation reactions could 
induce cytotoxicity and regenerative cell proliferation leading to the development of bladder 
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cancer in rats.  Moreover, Cohen et al. (2006) suggest that arsenicals induce cancer via non-
genotoxic mechanisms involving cytotoxicity and regenerative cell proliferation, thus arsenic 
compounds could exhibit a threshold, nonlinear dose-response relationship.     
    Another complicating factor in establishing a link between arsenic exposure and 
carcinogenesis (particularly at low level exposures) include confounding factors such as 
gender, smoking, nutritional status, genetic susceptibility, and exposure to radon (Tapio and 
Grosche, 2006).  An important example of genetic susceptibility would include differential 
rates of arsenic methylation, especially considering that DMAs3+ seems to accumulate in the 
lungs.  One other factor that complicates the risk assessment process is that the latency period 
in humans for developing arsenic-related cancer appears to be between 30-50 years (Tapio 
and Grosche, 2006).  As discussed in chapter 1 multiple hypothesis have been proposed to 
explain arsenic-induced carcinogenesis.  Some of these include the stimulation of cell 
proliferation.  As discussed above cell proliferation and cytotoxicity are two mechanisms by 
which chemical might induce cancer.  From our data and those of others, iAs3+ might induce 
cell proliferation at relatively low levels.  Moreover, we observed that DMAs3+ was more 
cytotoxic than iAs3+.  Because both compounds can occur simultaneously in a cell on any 
given moment there exists the possibility that low doses of DMA3+ cause necrotic cell death 
whereas iAs3+ stimulates cell proliferation.  This could be a possible mechanism for arsenic-
induced carcinogenesis in the lungs, as this organ tends to accumulate dimethylarsine.   
    Yamauchi and Yamamura (1983) analyzed the tissue concentrations of arsenic and its 
metabolites from deceased patients from Japan (not exposed to arsenic).  The authors report 
wet weight concentrations of iAs in lungs of 96.9 ng/g and DMA of 7.6 ng/g.  Based on the 
arsenic concentrations we obtained after exposing the BEAS-2B cells to 10 µM iAs3+ we 
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estimate the dry weight of As in the cells to be ~12,000 ng/g.  In a similar fashion the dry 
weight of As in the cells exposed to 1 µM DMAs3+ calculate to be ~41,500 ng/g.  If we 
assume that the difference between wet weight and dry weight is approximately ten-fold 
(Lyengar et al., 1978) then the wet weight values we obtained should be ~1200 ng As/g in 
the iAs3+ exposed cells and 4150 ng As/g in the DMAs3+ exposed cells.  These values are one 
and two orders of magnitude higher than those reported for the adult patients.  However, the 
results from the patients come from an unexposed population.  Still, we could speculate that 
with relatively low exposures the concentrations of arsenic in the lungs should not induce 
increased cytotoxicity or DNA damage (in the case of DMAs3+).  Whether these 
concentrations could induce increased cell proliferation would require further study.        
    Another hypothesis that might explain arsenic-induced carcinogenesis is the induction of 
oxidative stress.  On our experiments we found indirect evidence that supports this 
hypothesis as GSH depletion and supplementation affected DMAs3+-induced sensitization to 
DNA damage caused by H2O2.  Once again this could also partially explain arsenic-induced 
lung carcinogenesis. 
    An important issue to consider is how the doses we used compare to human exposures.  In 
the United States the current limit for arsenic in water is 10 µg/L.  In other countries such as 
Bangladesh the limit has been retained at 50 µg/L.  A concentration of 10 µM NaAsO2 
(which we used on our cells) is roughly equivalent to 741 µg/L elemental arsenic.  Thus, the 
concentration we used is more than an order of magnitude larger than the water standard.  
However, the uptake of arsenic by cultured lung cells may be different to that in the 
gastrointestinal tract epithelium.  Moreover, issues such as genetic susceptibility, preexisting 
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health conditions, exposure to other pollutants, and age can make a person more susceptible 
to the harmful effects of a chemical.      
    We should also understand what possible role arsenic might play in air pollution related 
health effects.  As mentioned in the introduction most of our knowledge of arsenic-induced 
carcinogenicity in humans (from air exposures) comes from occupational studies.  In many of 
the cases described it took dozens of years of exposure to relatively high doses of the metal 
for any effects to show.  Modern regulations (at least in the USA) when followed should 
provide adequate protection to employees in hazardous environments.  In occupational 
settings where the risk of inhaling arsenic could be present (such as in non-ferrous smelters) 
we also should know the concentration of the arsenical in the air and the duration of the 
exposure of the employee.  This data simplifies the risk management process for those 
employees.  The current 8 h time-weighted average (TWA) for occupational As exposure (in 
the European Union) is 0.1 mg/m3.  In the United States the permissible exposure limit given 
by the mine safety and health administration is 0.5 mg/m3 (Tapio and Grosche, 2006).  
During an 8 h period a human might inhale approximately 7.2 m3 of air (Ghio and Devlin, 
2001).  Using as an example the 8 h-TWA (0.1 mg/m3) the amount of arsenic inhaled by an 
employee during the 8 h time period is approximately 0.7 mg As.  If we assume 25% 
deposition (typical for PM, (US EPA, 2004)) of the arsenic and a lung surface area of 75 m2 
(West, 1985) the theoretical dose received by the employee is approximately 0.023 µg/cm2.  
On our in vitro exposures the cells received 10 µM NaAsO2 which is equivalent to 1.29 
µg/ml (arsenite).  This translates to approximately 7.74 µg arsenite per well (on the 6-well 
plate with 6 ml final volume) or approximately 0.8 µg arsenite/cm2.  Thus, our cell exposures 
are also an order of magnitude larger than a hypothetical air exposure.  However, the in vitro 
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system can be predictive of in vivo responses.   In experiments using Utah Valley PM 
extracted from filters, excellent agreement in effects (e.g., inflammation, cell injury) has been 
found between PM exposure of BEAS-2B cells in vitro (where cells were exposed to 250 µg 
PM/10 cm2) and in vivo responses in humans where subjects were instilled with 250 µg PM 
over 5-10 m2 of the lung surface (Ghio et al., 2004).           
    It is much more difficult to tease out the possible role that ambient air concentrations of 
arsenic might play in inducing health effects.  This stems mainly from the fact that ambient 
air arsenic concentrations are much lower than those found on occupational settings.  
Moreover, arsenic and other metals are mostly associated with particles, especially those that 
have a mass median aerodynamic diameter of less than 2.5 µm (Schroeder et al., 1987).  It is 
known that PM can alter the expression of inflammatory mediators, up-regulate the 
expression of adhesion molecules on inflammatory cells (Salvi et al., 1999), and cause lipid 
peroxidation (Madden et al., 1999).  The main consequence of PM exposure is usually 
inflammation.  It is hypothesized that airborne PM might induce their health effects in part by 
delivering transition metals to the airways in a soluble form (e.g. as humates, citrates, or 
sulfates).  Once in the lung, the metals produce ROS and lipid peroxidation products via 
Fenton-like chemistry promoting the expression of cytokines and cytotoxicity in airway 
epithelial cells (Frampton et al., 1999).  The role that minute levels of arsenic might play in 
inducing health effects is unknown, though we know it can potentiate the effects of other 
carcinogens (e.g. benzo[a]pyrene).  If a person is exposed to arsenic via drinking water and is 
also exposed to PM (creating oxidative conditions) it is very likely that some additive or 
synergistic effect might occur.  For instance it has been shown that exposure to PM and 
ozone (a potent oxidant air pollutant) can cause increased adhesion and uptake of the 
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particles in bronchial epithelial cells and generates ROS (Churg, 2003).  Moreover, Voter et 
al. (2001) demonstrated that smokers experience a greater burden to ROS than non-smokers 
after exposure to ozone.      
    In the biological and physical sciences we observe with each new discovery how things are 
interrelated.  The recent advent of genomic and proteomic sciences and the complexity in the 
regulation of gene expression highlight this concept.  In toxicology we also observe how one 
particular agent might affect an organism in multiple ways.  Arsenic is perhaps a perfect 
example to describe this point.  From the literature search presented on chapter 1 we can 
appreciate the magnitude of effects that arsenic can generate, ranging from affecting gene 
expression to the induction of oxidative stress.  In fig. 5-1 we summarize our most relevant 
findings and how they relate to one another.   
    We have also discussed the importance of the balance between oxidant/antioxidant 
processes in the body.  Humans are normally exposed to numerous substances all at once.  
Many chemical compounds to which we are exposed can exert their effects through the 
generation of ROS.  This includes airborne particles, hydrogen peroxide and possibly arsenic.  
The continuous exposure to ROS can lead to sustained DNA damage and possibly cancer.  In 
this project we presented evidence that suggests that arsenic might potentiate the DNA 
damage induced by hydrogen peroxide.  Given the role H2O2 plays in the lungs and the fact 
that arsenicals are known to potentiate the effects of other agents the results from this 
research might provide an important contribution to the continuous effort of trying to 
ascertain how these compounds induce cancer. 
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Future Directions: 
 
1. Establish whether in vitro findings are applicable to human populations by 
performing molecular epidemiology studies.  By combining a traditional 
epidemiology study (which accounts for differences in diet and lifestyle) and the use 
of biomarkers it could be possible to gather evidence on the role of oxidative stress in 
arsenic-exposed populations.  Some of the more relevant biomarkers could include 
oxidative DNA lesions, antioxidant levels, and by-products of ROS exposure in blood 
or other surrogate tissue.  
 
2. Arsenic induced sensitization to DNA damage might be an important carcinogenic 
pathway in susceptible individuals (e.g. those with altered metabolic or DNA repair 
pathways or those with chronic pulmonary disease).  Studying genetic 
polymorphisms in antioxidant and DNA repair genes could improve the current risk 
assessment for arsenic compounds. 
 
3. Perform more detailed studies involving the relationship between intracellular arsenic 
transport and arsenic effects.  This is particularly relevant with iAs3+, whose effects 
on DNA damage seem to be more challenging to detect.    
 
4. Study the possible role arsenic plays on PM toxicity.  Given the prominent role 
transition metals seem to play on PM-induced morbidity and mortality, it could be 
useful to discern the possible contribution of As compounds to such effects. 
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5. Investigate whether the results observed correlate with the non-carcinogenic adverse 
health effects posed by arsenic.  Oxidative stress has been implicated in the 
pathogenesis of neurodegenerative disease (Barnham et al., 2004), chronic obstructive 
pulmonary disease (Langen et al., 2003), diabetic vascular disease (Yorek, 2003), 
heart disease (Shah & Channon, 2004), and others (Cooke et al., 2003).  Moreover, 
arsenic is implicated with diabetes (Tseng, 2004), cardiovascular disease, and 
neurologic disorders (Tchounwou et al., 2003).  In vitro studies could be performed to 
examine the possible mechanisms by which arsenic induces non-cancer health effects.  
These results could be taken into account when designing a final risk assessment for 
arsenic.  Furthermore, a recent review of the EPA water research programs concluded 
that the agency should focus more resources towards the non-cancer endpoints 
associated with arsenic exposures (BNA, 2004). 
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Figure Legend: 
Figure 5-1.  Summary of findings and their relationship to arsenic-induced 
carcinogenesis.  I.  From the literature we know that iAs3+ should enter the cells via 
aquaglyceroporins 7 and 9, and is transported out via Mrp1 and p-gp.  When we blocked 
Mrp1 and p-gp pharmacologically we were able to increase intracellular arsenite levels but 
not arsenite sensitization to H2O2-induced DNA damage.  II. It is not clear how DMAs3+ 
enters the cells, but we found that the cells accumulate approximately 18% of the DMAs3+ 
after the exposure.  Moreover, DMAs3+ is more cytotoxic, induces SCGE detectable DNA 
damage directly, and sensitizes the cells to H2O2-induced DNA damage more efficiently than 
iAs3+.  III. DMT1 normally transports Fe2+ inside the cells where it is bound by ferritin in a 
less catalytically active form.  V4+ can downregulate the expression and activity of DMT1 
making the cell more sensitive to the DNA damaging effects of Fe and H2O2.  IV. We found 
that GSH might be an important factor in DMAs3+-induced sensitization to DNA damage 
caused by H2O2.  When GSH was depleted DMAs3+ potentiated the effects of H2O2, and 
when GSH was supplemented the effects of DMAs3+ were diminished.  The effects arsenite 
had were less clear but because of methodological limitations no definitive conclusion can be 
drawn yet.  V.  Another effect of DMT1 downregulation is the accumulation of extracellular 
Fe2+.  This ferrous iron can react with H2O2 (Fenton reaction) generating ROS.  These ROS 
can react with membrane lipids generating lipid hydroperoxides that can cause cellular 
damage.  Moreover, if GSH is depleted (by DMAs3+) the activity of GSH peroxidase could 
be affected leading to diminished detoxification of lipid hydroperoxides.  VI. Airborne PM is 
known to induce inflammation in airway epithelium.  This can be an indirect source of 
oxidants.    
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Figure 5-1 
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APPENDIX I 
 
Uptake of the known Mrp1 substrate 14C-doxorubicin- and the p-gp substrate 3H-
vincristine sulphate by the BEAS-2B cells.  
 
 
14C-doxorubicin-HCl (2.07 GBq/mmol) and 3H-vincristine sulphate (222 GBq/mmol) were 
purchased from GE Healthcare/Amersham Biosciences (Buckinghamshire, UK).  The BEAS-
2B cells were seeded onto 12-well cell culture plates and incubated with varying 
concentrations of the inhibitors for 1 or 3 h.  Subsequently we added the known Mrp1 
substrate 14C-doxorubicin-HCl (1 X 105 DPM per well dissolved in KGM/ethanol) or the p-
gp substrate 3H-vincristine sulphate (1 X 105 DPM per well dissolved in KGM/ethanol) (final 
ethanol concentration was <0.1%).  The levels of the substrates in the cell lysates (after 
incubation in dH2O) was determined by standard liquid scintillation counting (Packard Tri-
Carb 1500, Packard Instrument Company, Meriden, CT) every hour for a period of 4 h. The 
trypan blue (Gibco, Frederick, MD) dye exclusion assay was used to examine cell viability 
on cells not treated with the radiolabeled ligands.  Based on the results obtained from uptake 
and cytotoxicity (cells >90% viable after 4 h and no significant detachment or other gross 
morphological changes) we chose combinations of 4 µg/ml indomethacin together with 10 
µg/ml verapamil.  When 10 µM iAs3+ is added to the inhibitor combination for 4 h cell 
viability remains unchanged.   
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Figure Legends: 
Figure A-1.  Cellular content of 14C-doxorubicin by the BEAS-2B cells after a 1 h exposure 
to 4µg/ml indomethacin, 10 µg/ml verapamil, and/or 10 µM iAs3+.   
 
Figure A-2.  Cellular content of 14C-doxorubicin by the BEAS-2B cells after a 3 h exposure 
to 4µg/ml indomethacin, 10 µg/ml verapamil, and/or 10 µM iAs3+.   
 
Figure A-3.  Cellular content of 3H-vincristine by the BEAS-2B cells after a 1 h exposure to 
4µg/ml indomethacin, 10 µg/ml verapamil, and/or 10 µM iAs3+.   
 
Figure A-4.  Cellular content of 3H-vincristine by the BEAS-2B cells after a 3 h exposure to 
4µg/ml indomethacin, 10 µg/ml verapamil, and/or 10 µM iAs3+.   
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Figure A-1 
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Figure A-2 
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Figure A-3 
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Figure A-4 
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